Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Diseases

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 406 articles:
HTML format



Single Articles


    July 2021
  1. CULLARO G, Rubin JB, Fortune BE, Crawford CV, et al
    Association Between Kidney Dysfunction Types and Mortality Among Hospitalized Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jul 22. pii: 10.1007/s10620-021-07159.
    PubMed     Abstract available


  2. HAI Y, Chong W, Eisenbrey JR, Forsberg F, et al
    Network Meta-Analysis: Noninvasive Imaging Modalities for Identifying Clinically Significant Portal Hypertension.
    Dig Dis Sci. 2021 Jul 17. pii: 10.1007/s10620-021-07168.
    PubMed     Abstract available


  3. BARNES EL, Grimm-Vavlitis JL, Long MD
    Impact of Virtual Interviews on Gastroenterology and Hepatology Fellowship Recruitment.
    Dig Dis Sci. 2021 Jul 15. pii: 10.1007/s10620-021-07123.
    PubMed    


  4. LIU J, He X, Zou Y, Wang K, et al
    Circular RNA Circ-STIL Contributes to Cell Growth and Metastasis in Hepatocellular Carcinoma via Regulating miR-345-5p/AQP3 Axis.
    Dig Dis Sci. 2021 Jul 6. pii: 10.1007/s10620-021-07054.
    PubMed     Abstract available


    June 2021
  5. DELEURAN T, Watson H, Vilstrup H, Jepsen P, et al
    Risk Factors for Hepatic Hydrothorax in Cirrhosis Patients with Ascites - A Clinical Cohort Study.
    Dig Dis Sci. 2021 Jun 30. pii: 10.1007/s10620-021-07134.
    PubMed     Abstract available


  6. ZHOU K, Dodge JL, Yuan L, Terrault NA, et al
    Metabolic Risk Profiles for Hepatic Steatosis Differ by Race/Ethnicity: An Elastography-Based Study of US Adults.
    Dig Dis Sci. 2021 Jun 26. pii: 10.1007/s10620-021-07124.
    PubMed     Abstract available


  7. FRENETTE CT, Levy C, Saab S
    Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door.
    Dig Dis Sci. 2021 Jun 24. pii: 10.1007/s10620-021-07075.
    PubMed     Abstract available


  8. HA NB, Cho SJ, Mohamad Y, Kent D, et al
    Visceral Adipose Tissue Inflammation and Radiographic Visceral-to-Subcutaneous Adipose Tissue Ratio in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jun 16. pii: 10.1007/s10620-021-07099.
    PubMed     Abstract available


  9. DAHIYA M, Eboreime E, Hyde A, Rahman S, et al
    International Classification of Diseases Codes are Useful in Identifying Cirrhosis in Administrative Databases.
    Dig Dis Sci. 2021 Jun 6. pii: 10.1007/s10620-021-07076.
    PubMed     Abstract available


    May 2021
  10. PENG X, Tian A, Li J, Mao Y, et al
    Diagnostic Value of FibroTouch and Non-invasive Fibrosis Indexes in Hepatic Fibrosis with Different Aetiologies.
    Dig Dis Sci. 2021 May 31. pii: 10.1007/s10620-021-07049.
    PubMed     Abstract available


  11. CACCAMO G, Franze MS, Saffioti F, Pitrone C, et al
    Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate.
    Dig Dis Sci. 2021 May 26. pii: 10.1007/s10620-021-07047.
    PubMed     Abstract available


  12. PINYOPORNPANISH K, Al-Yaman W, Dasarathy S, Romero-Marrero C, et al
    Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.
    Dig Dis Sci. 2021 May 23. pii: 10.1007/s10620-021-07048.
    PubMed     Abstract available


  13. LI X, Lv J, Hou L, Guo X, et al
    Circ_0001955 Acts as a miR-646 Sponge to Promote the Proliferation, Metastasis and Angiogenesis of Hepatocellular Carcinoma.
    Dig Dis Sci. 2021 May 22. pii: 10.1007/s10620-021-07053.
    PubMed     Abstract available


  14. SERPER M
    Monitoring for Ascites in Cirrhosis Using Patient-Generated Health Data: No Longer a Remote Possibility.
    Dig Dis Sci. 2021 May 18. pii: 10.1007/s10620-021-07020.
    PubMed    


  15. YU B, Zhou S, Liang H, Ye Q, et al
    Development and Validation of a Novel Circulating miRNA-Based Diagnostic Score for Early Detection of Hepatocellular Carcinoma.
    Dig Dis Sci. 2021 May 12. pii: 10.1007/s10620-021-07031.
    PubMed     Abstract available


  16. BLOOM PP, Ventoso M, Tapper E, Ha J, et al
    A Telemonitoring Intervention for Cirrhotic Ascites Management Is Cost-Saving.
    Dig Dis Sci. 2021 May 6. pii: 10.1007/s10620-021-07013.
    PubMed     Abstract available


  17. TO C, Liu L, Satoskar RS, Thuluvath PJ, et al
    Diabetic Hepatosclerosis in a Woman with Maturity-Onset Diabetes of the Young Type 3.
    Dig Dis Sci. 2021 May 3. pii: 10.1007/s10620-021-07005.
    PubMed    


  18. RICH NE, Parvathaneni A, Sen A, Odewole M, et al
    High Neutrophil-Lymphocyte Ratio and Delta Neutrophil-Lymphocyte Ratio Are Associated with Increased Mortality in Patients with Hepatocellular Cancer.
    Dig Dis Sci. 2021 May 3. pii: 10.1007/s10620-021-07001.
    PubMed     Abstract available


    March 2021
  19. LIN RX, Zhan GF, Wu JC, Fang H, et al
    LncRNA SNHG14 Sponges miR-206 to Affect Proliferation, Apoptosis, and Metastasis of Hepatocellular Carcinoma Cells by Regulating SOX9.
    Dig Dis Sci. 2021 Mar 29. pii: 10.1007/s10620-021-06920.
    PubMed     Abstract available


  20. MAHMUD N, Asrani SK, Reese PP, Kaplan DE, et al
    Race Adjustment in eGFR Equations Does Not Improve Estimation of Acute Kidney Injury Events in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Mar 24. pii: 10.1007/s10620-021-06943.
    PubMed     Abstract available


  21. LIN K, Huang Q, Zeng J, Ding Z, et al
    Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection.
    Dig Dis Sci. 2021 Mar 16. pii: 10.1007/s10620-020-06797.
    PubMed     Abstract available


  22. PERISETTI A, Goyal H
    Successful Distancing: Telemedicine in Gastroenterology and Hepatology During the COVID-19 Pandemic.
    Dig Dis Sci. 2021 Mar 3. pii: 10.1007/s10620-021-06874.
    PubMed     Abstract available


    February 2021
  23. MIRAGLIA R, Maruzzelli L, Luca A
    Transjugular Intrahepatic Portosystemic Shunt: A Single-Centre Mid-term Experience Using the Viatorr Controlled-Expansion Stent.
    Dig Dis Sci. 2021 Feb 27. pii: 10.1007/s10620-021-06867.
    PubMed    


  24. WANG X, Luo X, Yang L
    Risk Factors for Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt: Beyond Stent Diameter.
    Dig Dis Sci. 2021 Feb 26. pii: 10.1007/s10620-021-06868.
    PubMed    


  25. KANG N, Chung JW, Jang ES, Jeong SH, et al
    Computed Tomography-Measured Liver Volume Predicts the Risk of Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients.
    Dig Dis Sci. 2021 Feb 25. pii: 10.1007/s10620-020-06762.
    PubMed     Abstract available


  26. XU YP, Dong ZN, Zhou YQ, Zhao YJ, et al
    Role of eIF3C Overexpression in Predicting Prognosis of Intrahepatic Cholangiocarcinoma.
    Dig Dis Sci. 2021 Feb 12. pii: 10.1007/s10620-021-06878.
    PubMed     Abstract available


  27. CHEN YC, Hsu CW, Jeng WJ, Lin CY, et al
    Advanced Liver Fibrosis Is Associated with Necroinflammatory Grade but Not Hepatic Steatosis in Chronic Hepatitis B Patients.
    Dig Dis Sci. 2021 Feb 10. pii: 10.1007/s10620-020-06761.
    PubMed     Abstract available


  28. BIE C, Chen Y, Tang H, Li Q, et al
    Insulin-Like Growth Factor 1 Receptor Drives Hepatocellular Carcinoma Growth and Invasion by Activating Stat3-Midkine-Stat3 Loop.
    Dig Dis Sci. 2021 Feb 9. pii: 10.1007/s10620-021-06862.
    PubMed     Abstract available


  29. STERLING RK, King WC, Khalili M, Kleiner DE, et al
    Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults.
    Dig Dis Sci. 2021 Feb 8. pii: 10.1007/s10620-021-06860.
    PubMed     Abstract available


  30. ZHANG D, Zhang Y, Zhang X, Zhai H, et al
    Circ_0091579 Serves as a Tumor-Promoting Factor in Hepatocellular Carcinoma Through miR-1225-5p/PLCB1 Axis.
    Dig Dis Sci. 2021 Feb 8. pii: 10.1007/s10620-021-06861.
    PubMed     Abstract available


  31. NAM JY, Lee YB, Lee JH, Yu SJ, et al
    A Prognostic Prediction Model of Transarterial Radioembolization in Hepatocellular Carcinoma: SNAP-HCC.
    Dig Dis Sci. 2021 Feb 4. pii: 10.1007/s10620-021-06843.
    PubMed     Abstract available


  32. ZHOU SN, Pan WT, Pan MX, Luo QY, et al
    Comparison of Immune Microenvironment Between Colon and Liver Metastatic Tissue in Colon Cancer Patients with Liver Metastasis.
    Dig Dis Sci. 2021;66:474-482.
    PubMed     Abstract available


  33. PATIDAR KR, Davis BC, Slaven JE, Ghabril MS, et al
    Admission Factor V Predicts Transplant-Free Survival in Acute Liver Failure.
    Dig Dis Sci. 2021;66:619-627.
    PubMed     Abstract available


    January 2021
  34. WU M, Jiang L
    Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.
    Dig Dis Sci. 2021 Jan 26. pii: 10.1007/s10620-021-06832.
    PubMed     Abstract available


  35. LI J, Bao S, Wang L, Wang R, et al
    CircZKSCAN1 Suppresses Hepatocellular Carcinoma Tumorigenesis by Regulating miR-873-5p/Downregulation of Deleted in Liver Cancer 1.
    Dig Dis Sci. 2021 Jan 13. pii: 10.1007/s10620-020-06789.
    PubMed     Abstract available


  36. ZHAO L, Ma N, Liu G, Mao N, et al
    Lidocaine Inhibits Hepatocellular Carcinoma Development by Modulating circ_ITCH/miR-421/CPEB3 Axis.
    Dig Dis Sci. 2021 Jan 12. pii: 10.1007/s10620-020-06787.
    PubMed     Abstract available


  37. XU R, Yin S, Zheng M, Pei X, et al
    Circular RNA circZFR Promotes Hepatocellular Carcinoma Progression by Regulating miR-375/HMGA2 Axis.
    Dig Dis Sci. 2021 Jan 12. pii: 10.1007/s10620-020-06805.
    PubMed     Abstract available


  38. TONTHAT A, Bui D, Romero M, Lo E, et al
    A Case of Benign Hepatic Cyst with Supra-elevated Cyst Fluid Tumor Markers.
    Dig Dis Sci. 2021 Jan 6. pii: 10.1007/s10620-020-06727.
    PubMed    


  39. OU H, Liu Q, Lin J, He W, et al
    Pseudogene Annexin A2 Pseudogene 1 Contributes to Hepatocellular Carcinoma Progression by Modulating Its Parental Gene ANXA2 via miRNA-376a-3p.
    Dig Dis Sci. 2021 Jan 4. pii: 10.1007/s10620-020-06734.
    PubMed     Abstract available


  40. MACHADO P, Gupta I, Gummadi S, Stanczak M, et al
    Hepatic Vein Contrast-Enhanced Ultrasound Subharmonic Imaging Signal as a Screening Test for Portal Hypertension.
    Dig Dis Sci. 2021 Jan 4. pii: 10.1007/s10620-020-06790.
    PubMed     Abstract available


  41. BALDIN C, Piedade J, Guimaraes L, Victor L, et al
    CLIF-C AD Score Predicts Development of Acute Decompensations and Survival in Hospitalized Cirrhotic Patients.
    Dig Dis Sci. 2021 Jan 3. pii: 10.1007/s10620-020-06791.
    PubMed     Abstract available


  42. HUANG Y, Chu P, Bao G
    Silencing of Long Non-coding RNA TTN-AS1 Inhibits Hepatocellular Carcinoma Progression by the MicroRNA-134/ITGB1 Axis.
    Dig Dis Sci. 2021 Jan 2. pii: 10.1007/s10620-020-06737.
    PubMed     Abstract available


  43. HSU CY, Parikh ND, Huo TI, Tapper EB, et al
    Comparison of Seven Noninvasive Models for Predicting Decompensation and Hospitalization in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jan 2. pii: 10.1007/s10620-020-06763.
    PubMed     Abstract available


  44. CAVAZZA A, McPhail MJ
    Absolutely FABulous? FABP-1 in Non-acetaminophen-related Acute Liver Failure.
    Dig Dis Sci. 2021;66:10-11.
    PubMed    


  45. ABBASS A, Khalid S, Farooq U, Rakov N, et al
    If DILI Is Suspected, Don't Dally.
    Dig Dis Sci. 2021;66:52-55.
    PubMed    


  46. PATEL HK, Saxena R, Rush N, Patel SK, et al
    A Comparative Study of 22G versus 19G Needles for EUS-Guided Biopsies for Parenchymal Liver Disease: Are Thinner Needles Better?
    Dig Dis Sci. 2021;66:238-246.
    PubMed     Abstract available


  47. KARVELLAS CJ, Speiser JL, Tremblay M, Lee WM, et al
    Elevated Serum Liver-Type Fatty Acid Binding Protein Levels in Non-acetaminophen Acute Liver Failure Patients with Organ Dysfunction.
    Dig Dis Sci. 2021;66:273-283.
    PubMed     Abstract available


  48. KIM D, Yoo ER, Li AA, Tighe SP, et al
    Trends in Hospitalizations for Clostridioides difficile Infection in End-Stage Liver Disease, 2005-2014.
    Dig Dis Sci. 2021;66:296-307.
    PubMed     Abstract available


    December 2020
  49. BERGQUIST JR, Li AY, Chang EM, Scott GD, et al
    Nearing the Summit: Associating Liver Partitioning and Portal Ligation for Staged Hepatectomy (ALPPS) in Progressive Carcinoid Disease.
    Dig Dis Sci. 2020;65:3482-3485.
    PubMed    


  50. LI Q, Rempel JD, Ball TB, Aukema H, et al
    Plasma Oxylipins Levels in Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2020;65:3605-3613.
    PubMed     Abstract available


    November 2020
  51. KLOSTER ML, Ren A, Shah KY, Alqadi MM, et al
    High Incidence of Hepatic Encephalopathy After Viatorr Controlled Expansion Transjugular Intrahepatic Portosystemic Shunt Creation.
    Dig Dis Sci. 2020 Nov 24. pii: 10.1007/s10620-020-06716.
    PubMed     Abstract available


  52. O'LEARY JG, Rajender Reddy K, Tandon P, Biggins SW, et al
    Increased Risk of ACLF and Inpatient Mortality in Hospitalized Patients with Cirrhosis and Hepatic Hydrothorax.
    Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06677.
    PubMed     Abstract available


  53. NAYMAGON L, Tremblay D, Zubizarreta N, Moshier E, et al
    Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Thrombosis.
    Dig Dis Sci. 2020 Nov 5. pii: 10.1007/s10620-020-06695.
    PubMed     Abstract available


  54. BERGQUIST JR, Li AY, Javadi CS, Chima RS, et al
    Too Big to Fail: Successful Resection of a Large Hepatocellular Carcinoma with Portal Tumor Thrombus.
    Dig Dis Sci. 2020 Nov 3. pii: 10.1007/s10620-020-06682.
    PubMed    


  55. ABY ES, Pham NV, Yum JJ, Dong TS, et al
    Frailty Does Not Impact Caregiver Burden in Patients with Cirrhosis.
    Dig Dis Sci. 2020 Nov 2. pii: 10.1007/s10620-020-06687.
    PubMed     Abstract available


  56. GREWAL J, Benhammou J, Patel PV, Saab S, et al
    Casting a Wider NET: An Unusual Cause of Acute Liver Failure in a Pregnant Patient.
    Dig Dis Sci. 2020;65:3102-3105.
    PubMed     Abstract available


  57. STINE JG, Xu D, Schmitz K, Sciamanna C, et al
    Exercise Attenuates Ribosomal Protein Six Phosphorylation in Fatty Liver Disease.
    Dig Dis Sci. 2020;65:3238-3243.
    PubMed     Abstract available


  58. SINGH A, Amin H, Garg R, Gupta M, et al
    Increased Prevalence of Obesity and Metabolic Syndrome in Patients with Alcoholic Fatty Liver Disease.
    Dig Dis Sci. 2020;65:3341-3349.
    PubMed     Abstract available


  59. CHEN HW, Ferrando A, White MG, Dennis RA, et al
    Home-Based Physical Activity and Diet Intervention to Improve Physical Function in Advanced Liver Disease: A Randomized Pilot Trial.
    Dig Dis Sci. 2020;65:3350-3359.
    PubMed     Abstract available


  60. ZHANG C, Wu Y, Yuan S, Dou X, et al
    Characteristics of Drug-Induced Liver Injury in Northeast China: Disease Spectrum and Drug Types.
    Dig Dis Sci. 2020;65:3360-3368.
    PubMed     Abstract available


    October 2020
  61. WANG B, Zhao K, Hu W, Ding Y, et al
    Protective Mechanism of MIF Inhibitor ISO-1 on Intrahepatic Bile Duct Cells in Rats with Severe Acute Pancreatitis.
    Dig Dis Sci. 2020 Oct 29. pii: 10.1007/s10620-020-06674.
    PubMed     Abstract available


  62. CLARKE K, Bilal M, Sanchez-Luna SA, Dalessio S, et al
    Impact of COVID-19 Pandemic on Training: Global Perceptions of Gastroenterology and Hepatology Fellows in the USA.
    Dig Dis Sci. 2020 Oct 19. pii: 10.1007/s10620-020-06655.
    PubMed     Abstract available


  63. JI C, Hong X, Lan B, Lin Y, et al
    Circ_0091581 Promotes the Progression of Hepatocellular Carcinoma Through Targeting miR-591/FOSL2 Axis.
    Dig Dis Sci. 2020 Oct 11. pii: 10.1007/s10620-020-06641.
    PubMed     Abstract available


  64. MUNOZ AE, Pollarsky F, Marino M, Cartier M, et al
    Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury.
    Dig Dis Sci. 2020 Oct 9. pii: 10.1007/s10620-020-06630.
    PubMed     Abstract available


  65. ATHYROS VG, Katsiki N, Mikhailidis DP
    NAFLD and Statins.
    Dig Dis Sci. 2020;65:3052-3053.
    PubMed    


  66. ZHANG Z, Yao W, Yuan D, Huang F, et al
    Effects of Connexin 32-Mediated Lung Inflammation Resolution During Liver Ischemia Reperfusion.
    Dig Dis Sci. 2020;65:2914-2924.
    PubMed     Abstract available


    September 2020
  67. NATARAJAN Y, Tansel A, Patel P, Emelogu IK, et al
    Correction to: Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2020 Sep 29. pii: 10.1007/s10620-020-06619.
    PubMed     Abstract available


  68. CHEN VL, Hawa F, Berinstein JA, Reddy CA, et al
    Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19.
    Dig Dis Sci. 2020 Sep 27. pii: 10.1007/s10620-020-06618.
    PubMed     Abstract available


  69. XIAO F, Gao M, Yang J, He L, et al
    FAM172A Deletion May Enhance Hepatic Steatosis by Promoting ER Stress.
    Dig Dis Sci. 2020 Sep 18. pii: 10.1007/s10620-020-06601.
    PubMed     Abstract available


  70. TRIEU H, Patel A, Wells C, Saab S, et al
    Disparities in Mortality and Health Care Utilization for 460,851 Hospitalized Patients with Cirrhosis and Hepatic Encephalopathy.
    Dig Dis Sci. 2020 Sep 14. pii: 10.1007/s10620-020-06582.
    PubMed     Abstract available


  71. RITACCIO G, Stoleru G, Abutaleb A, Cross RK, et al
    Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare.
    Dig Dis Sci. 2020 Sep 7. pii: 10.1007/s10620-020-06588.
    PubMed     Abstract available


  72. SIMONS-LINARES CR, Abushamma S, Romero-Marrero C, Bhatt A, et al
    Clinical Outcomes of Acute Pancreatitis in Patients with Cirrhosis According to Liver Disease Severity Scores.
    Dig Dis Sci. 2020 Sep 6. pii: 10.1007/s10620-020-06575.
    PubMed     Abstract available


  73. SHAW J, Patidar KR, Reuter B, Hajezifar N, et al
    Focused Education Increases Hepatocellular Cancer Screening in Patients with Cirrhosis Regardless of Functional Health Literacy.
    Dig Dis Sci. 2020 Sep 5. pii: 10.1007/s10620-020-06583.
    PubMed     Abstract available


  74. PATEL A, Asch S, Antonio AL, Kanwal F, et al
    Measuring the Quality of Palliative Care for Patients with End-Stage Liver Disease.
    Dig Dis Sci. 2020;65:2562-2570.
    PubMed     Abstract available


  75. SHALIMAR, Sharma S, Gamanagatti SR, Chauhan A, et al
    Acute-on-Chronic Liver Failure in Budd-Chiari Syndrome: Profile and Predictors of Outcome.
    Dig Dis Sci. 2020;65:2719-2729.
    PubMed     Abstract available


  76. AYYAGARI S, Tan MC, Liu Y, El-Serag HB, et al
    Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients.
    Dig Dis Sci. 2020;65:2691-2699.
    PubMed     Abstract available


    August 2020
  77. DENG LX, Mehta N
    Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers.
    Dig Dis Sci. 2020 Aug 29. pii: 10.1007/s10620-020-06550.
    PubMed     Abstract available


  78. HYUN HK, Cho EJ, Park SY, Hong YM, et al
    Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study.
    Dig Dis Sci. 2020 Aug 28. pii: 10.1007/s10620-020-06533.
    PubMed     Abstract available


  79. REICHERT MC, Massmann A, Schulz A, Buecker A, et al
    Volume-Function Analysis (LiMAx Test) in Patients with HCC and Cirrhosis Undergoing TACE-A Feasibility Study.
    Dig Dis Sci. 2020 Aug 20. pii: 10.1007/s10620-020-06535.
    PubMed     Abstract available


  80. BALAKRISHNAN M, Seth A, Cortes-Santiago N, Jain S, et al
    External Validation of Four Point-of-Care Noninvasive Scores for Predicting Advanced Hepatic Fibrosis in a Predominantly Hispanic NAFLD Population.
    Dig Dis Sci. 2020 Aug 5. pii: 10.1007/s10620-020-06501.
    PubMed     Abstract available


  81. GRUTTADAURIA S, Pagano D, di Francesco F, Foglio A, et al
    Adult to Adult Living Donor Liver Transplantation in Recipients with Low MELD: A Strategy Intended to Overcome Donor Shortage.
    Dig Dis Sci. 2020 Aug 5. pii: 10.1007/s10620-020-06522.
    PubMed     Abstract available


  82. NATARAJAN Y, Tansel A, Patel P, Emologu K, et al
    Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2020 Aug 2. pii: 10.1007/s10620-020-06498.
    PubMed     Abstract available


  83. PALETI S, Li Y, Okwara C, McCarthy D, et al
    Liver Abscess: A Wolf in Sheep's Clothing.
    Dig Dis Sci. 2020;65:2221-2224.
    PubMed    


    July 2020
  84. BLOOM PP, Pasricha TS, Andersson KL, Pratt DS, et al
    Hepatology Consultants Often Disagree on Etiology of Abnormal Liver Biochemistries in COVID-19 but Agree on Management.
    Dig Dis Sci. 2020 Jul 29. pii: 10.1007/s10620-020-06495.
    PubMed     Abstract available


  85. CAO Y, Tao Q, Kao X, Zhu X, et al
    Hsa-circRNA-103809 Promotes Hepatocellular Carcinoma Development via MicroRNA-1270/PLAG1 Like Zinc Finger 2 Axis.
    Dig Dis Sci. 2020 Jul 18. pii: 10.1007/s10620-020-06416.
    PubMed     Abstract available


  86. JIANG L, Chu H, Gao B, Lang S, et al
    Transcriptomic Profiling Identifies Novel Hepatic and Intestinal Genes Following Chronic Plus Binge Ethanol Feeding in Mice.
    Dig Dis Sci. 2020 Jul 15. pii: 10.1007/s10620-020-06461.
    PubMed     Abstract available


  87. LE L, Kullar R, Saleh HM, Saab S, et al
    Preferred Noninvasive Testing for Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2020 Jul 15. pii: 10.1007/s10620-020-06382.
    PubMed     Abstract available


  88. XIE X, Dou CY, Zhou Y, Zhou Q, et al
    MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis.
    Dig Dis Sci. 2020 Jul 9. pii: 10.1007/s10620-020-06460.
    PubMed     Abstract available


  89. KOTWAL V, Mbachi C, Wang Y, Attar B, et al
    A Novel Score to Predict Esophageal Varices in Patients with Compensated Advanced Chronic Liver Disease.
    Dig Dis Sci. 2020 Jul 9. pii: 10.1007/s10620-020-06456.
    PubMed     Abstract available


  90. MALLEPALLY N, Bilal M, Hernandez-Barco YG, Simons M, et al
    The New Virtual Reality: How COVID-19 Will Affect the Gastroenterology and Hepatology Fellowship Match.
    Dig Dis Sci. 2020 Jul 1. pii: 10.1007/s10620-020-06432.
    PubMed    


  91. MORNINGSTAR JE, Syn WK, Litwin SE
    The Emerging Epidemic of Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: True, True, and Related?
    Dig Dis Sci. 2020;65:1885-1887.
    PubMed    


  92. SHRESTHA MP, Senussi N, Volpicelli N, McCarthy D, et al
    Tangled Up in Red Cells: A Large Liver Mass with Intravascular Hemolysis.
    Dig Dis Sci. 2020;65:1960-1963.
    PubMed    


  93. LABENZ C, Huber Y, Michel M, Nagel M, et al
    Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany.
    Dig Dis Sci. 2020;65:2112-2119.
    PubMed     Abstract available


    June 2020
  94. LOUISSAINT J, Foster C, Harding-Theobald E, Lok AS, et al
    Social Support Does Not Modify the Risk of Readmission for Patients with Decompensated Cirrhosis.
    Dig Dis Sci. 2020 Jun 23. pii: 10.1007/s10620-020-06421.
    PubMed     Abstract available


  95. GOTO T, Selzner M
    Low-Pressure Tactic: A Novel Intrahepatic Shunt Improves Outcomes in Experimental Small-for-Size Syndrome.
    Dig Dis Sci. 2020 Jun 18. pii: 10.1007/s10620-020-06385.
    PubMed    


  96. KEGASAWA T, Sakamori R, Maesaka K, Yamada R, et al
    Lower Serum Sodium Levels Are Associated with the Therapeutic Effect of Sorafenib on Hepatocellular Carcinoma.
    Dig Dis Sci. 2020 Jun 17. pii: 10.1007/s10620-020-06380.
    PubMed     Abstract available


  97. HO SY, Hsu CY, Liu PH, Lee RC, et al
    Albumin-Bilirubin (ALBI) Grade-Based Nomogram for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
    Dig Dis Sci. 2020 Jun 16. pii: 10.1007/s10620-020-06384.
    PubMed     Abstract available


  98. DANFORD CJ, Lee JY, Strohbehn IA, Corey KE, et al
    Development of an Algorithm to Identify Cases of Nonalcoholic Steatohepatitis Cirrhosis in the Electronic Health Record.
    Dig Dis Sci. 2020 Jun 13. pii: 10.1007/s10620-020-06388.
    PubMed     Abstract available


  99. LONG MD, Raffals L, Williams R
    Program Directors' Perspectives of Gastroenterology and Hepatology Fellowship Application.
    Dig Dis Sci. 2020 Jun 13. pii: 10.1007/s10620-020-06378.
    PubMed    


  100. BARAKAT MT, Josephs S, Gugig R
    Return to Native Drainage: Duodenal Biliary Fistula Formation Following Pediatric Hepatobiliary Surgery with Roux-en-Y Reconstruction.
    Dig Dis Sci. 2020 Jun 12. pii: 10.1007/s10620-020-06372.
    PubMed    


  101. SHIN JW, Jeong J, Jung SW, Lee SB, et al
    Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir.
    Dig Dis Sci. 2020 Jun 10. pii: 10.1007/s10620-020-06375.
    PubMed     Abstract available


  102. TERBAH R, Gow P, Sinclair M, Testro A, et al
    Terlipressin for Type 1 Hepatorenal Syndrome.
    Dig Dis Sci. 2020 Jun 8. pii: 10.1007/s10620-020-06370.
    PubMed    


  103. LONARDO A, Targher G
    Cardiovascular Risk in NAFLD: An Intimate Relationship?
    Dig Dis Sci. 2020;65:1593-1595.
    PubMed    


  104. SHAO C, Ye J, Li F, Lin Y, et al
    Early Predictors of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease: Non-obese Versus Obese Patients.
    Dig Dis Sci. 2020;65:1850-1860.
    PubMed     Abstract available


    May 2020
  105. KHOKHAR MA, O'Beirne J
    Transjugular Intrahepatic Portosystemic Shunts for Hepatorenal Syndrome: TIPping the Scales in Whose Favor?
    Dig Dis Sci. 2020 May 29. pii: 10.1007/s10620-020-06351.
    PubMed    


  106. SHROFF H, Rinella ME
    Thanks to CLD for Small Favors: Reduced CVD Risk in Patients Awaiting Liver Transplantation.
    Dig Dis Sci. 2020 May 29. pii: 10.1007/s10620-020-06322.
    PubMed    


  107. LUI FH, Ma P, Helmy M, Hu KQ, et al
    Ultrasonographic (US) Two-Dimensional Measurement of Spleen Is Superior to Traditional Length Measurement Alone in Diagnosing Cirrhosis.
    Dig Dis Sci. 2020 May 23. pii: 10.1007/s10620-020-06332.
    PubMed     Abstract available


  108. CHAHAL D, Yoshida EM, Arbour L, Wallach JP, et al
    Post-partum Primary Biliary Cholangitis Preceded by Intrahepatic Cholestasis of Pregnancy in Three First Nation Patients.
    Dig Dis Sci. 2020 May 22. pii: 10.1007/s10620-020-06333.
    PubMed    


  109. FERRARESE A, Burra P, Senzolo M
    A Commentary on the Interplay Between Severity of Liver Disease and Bacterial Infection in Hospitalized Patients with Cirrhosis.
    Dig Dis Sci. 2020 May 8. pii: 10.1007/s10620-020-06278.
    PubMed    


  110. FAHAD H, Sarmini MT, Modaresi-Esfeh J
    Does Obesity Affect Outcomes of Transjugular Intrahepatic Portosystemic Shunt Placement?
    Dig Dis Sci. 2020 May 6. pii: 10.1007/s10620-020-06276.
    PubMed    


  111. CHEN X, Liu C, Ruan L
    G-Protein-Coupled Receptors 120 Agonist III Improves Hepatic Inflammation and ER Stress in Steatohepatitis.
    Dig Dis Sci. 2020 May 5. pii: 10.1007/s10620-020-06280.
    PubMed     Abstract available


  112. IZZY M, Shingina A
    Functional Status and Liver Disease Phenotype: Frailty, Thy Presence Is Ominous.
    Dig Dis Sci. 2020;65:1296-1298.
    PubMed    


  113. MUKTHINUTHALAPATI VVPK, Attar BM, Parra-Rodriguez L, Cabrera NL, et al
    Risk Factors, Management, and Outcomes of Pyogenic Liver Abscess in a US Safety Net Hospital.
    Dig Dis Sci. 2020;65:1529-1538.
    PubMed     Abstract available


    April 2020
  114. ZHANG G, Ma J, Xiong J, Huang X, et al
    Upregulation of Excision Repair Cross-Complementation Group 6-Like (ERCC6L) Promotes Tumor Growth in Hepatocellular Carcinoma.
    Dig Dis Sci. 2020 Apr 29. pii: 10.1007/s10620-020-06277.
    PubMed     Abstract available


  115. LIU GM, Zeng HD, Zhang CY, Xu JW, et al
    Identification of METTL3 as an Adverse Prognostic Biomarker in Hepatocellular Carcinoma.
    Dig Dis Sci. 2020 Apr 24. pii: 10.1007/s10620-020-06260.
    PubMed     Abstract available


  116. EL-SERAG HB, Sardell R, Thrift AP, Kanwal F, et al
    Texas Has the Highest Hepatocellular Carcinoma Incidence Rates in the USA.
    Dig Dis Sci. 2020 Apr 17. pii: 10.1007/s10620-020-06231.
    PubMed     Abstract available


  117. BLOOM PP
    A Call to Action: Novel Ways that Hepatologists Can Contribute to Patient Care During the COVID-19 Pandemic.
    Dig Dis Sci. 2020 Apr 13. pii: 10.1007/s10620-020-06251.
    PubMed    


  118. TESTINO G
    Transjugular Intrahepatic Porto Systemic Shunt for Hepatorenal Syndrome in Alcoholic Patients.
    Dig Dis Sci. 2020 Apr 13. pii: 10.1007/s10620-020-06243.
    PubMed    


  119. MOCTEZUMA-VELAZQUEZ C, Montano-Loza AJ, Meza-Junco J, Burak K, et al
    Selective Internal Radiation Therapy for Hepatocellular Carcinoma Across the Barcelona Clinic Liver Cancer Stages.
    Dig Dis Sci. 2020 Apr 12. pii: 10.1007/s10620-020-06245.
    PubMed     Abstract available


  120. SUN RF, Zhao CY, Chen S, Yu W, et al
    Androgen Receptor Stimulates Hexokinase 2 and Induces Glycolysis by PKA/CREB Signaling in Hepatocellular Carcinoma.
    Dig Dis Sci. 2020 Apr 9. pii: 10.1007/s10620-020-06229.
    PubMed     Abstract available


  121. TURKSEVEN S, Bolognesi M, Di Pascoli M
    Contribution of Splenic Resistance Arteries to Splanchnic Blood Overflow in Cirrhosis.
    Dig Dis Sci. 2020 Apr 2. pii: 10.1007/s10620-020-06233.
    PubMed     Abstract available


  122. TIEN PC, Duarte M, Roque A, Price J, et al
    MRE and ELF in Liver Fibrosis Assessment: Are Two Better Than One?
    Dig Dis Sci. 2020;65:928-930.
    PubMed    


  123. SHERIF ZA
    Unmasking a Stealth Killer: The Need for Increased Awareness of NASH.
    Dig Dis Sci. 2020;65:987-989.
    PubMed    


  124. KAPLAN DE
    A Matter of TACEte: Plain Vanilla or Combination?
    Dig Dis Sci. 2020;65:934-936.
    PubMed    


  125. DIPAOLA F, Trout AT, Walther AE, Gupta A, et al
    Congenital Portosystemic Shunts in Children: Associations, Complications, and Outcomes.
    Dig Dis Sci. 2020;65:1239-1251.
    PubMed     Abstract available


  126. SINGH A, Dhaliwal AS, Singh S, Kumar A, et al
    Awareness of Nonalcoholic Fatty Liver Disease Is Increasing but Remains Very Low in a Representative US Cohort.
    Dig Dis Sci. 2020;65:978-986.
    PubMed     Abstract available


    March 2020
  127. ZORI A, Villanueva F, Hatamleh D, Ismael M, et al
    Favorable Survival with Non-curative Treatments for Patients with Early-Stage Hepatocellular Carcinoma After Liver Transplant Denial.
    Dig Dis Sci. 2020 Mar 26. pii: 10.1007/s10620-020-06201.
    PubMed     Abstract available


  128. WANG C, Luo J, Chen Z, Ye M, et al
    MiR-375 Impairs the Invasive Capabilities of Hepatoma Cells by Targeting HIF1alpha Under Hypoxia.
    Dig Dis Sci. 2020 Mar 25. pii: 10.1007/s10620-020-06202.
    PubMed     Abstract available


  129. PATEL S, Siddiqui MB, Chandrakumaran A, Rodriguez VA, et al
    Progression to Cirrhosis Leads to Improvement in Atherogenic Milieu.
    Dig Dis Sci. 2020 Mar 18. pii: 10.1007/s10620-020-06196.
    PubMed     Abstract available


  130. O'LEARY JG, Tandon P, Reddy KR, Biggins SW, et al
    Underutilization of Hospice in Inpatients with Cirrhosis: The NACSELD Experience.
    Dig Dis Sci. 2020 Mar 7. pii: 10.1007/s10620-020-06168.
    PubMed     Abstract available


  131. LI J, Dong S, Ye M, Peng G, et al
    MicroRNA-489-3p Represses Hepatic Stellate Cells Activation by Negatively Regulating the JAG1/Notch3 Signaling Pathway.
    Dig Dis Sci. 2020 Mar 7. pii: 10.1007/s10620-020-06174.
    PubMed     Abstract available


  132. ZHANG L, Tai Y, Tang S, Zhao C, et al
    Compromised Ileal Mucus Barrier Due to Impaired Epithelial Homeostasis Caused by Notch1 Signaling in Cirrhotic Rats.
    Dig Dis Sci. 2020 Mar 6. pii: 10.1007/s10620-020-06178.
    PubMed     Abstract available


  133. SHAMA S, Liu W
    Omega-3 Fatty Acids and Gut Microbiota: A Reciprocal Interaction in Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2020;65:906-910.
    PubMed     Abstract available


  134. LECHNER S, Yee M, Limketkai BN, Pham EA, et al
    Fecal Microbiota Transplantation for Chronic Liver Diseases: Current Understanding and Future Direction.
    Dig Dis Sci. 2020;65:897-905.
    PubMed     Abstract available


    February 2020
  135. FRICKER ZP, Mukthinuthalapati VVPK, Akinyeye S, Chalasani N, et al
    MELD-Na Is More Strongly Associated with Risk of Infection and Outcomes Than Other Characteristics of Patients with Cirrhosis.
    Dig Dis Sci. 2020 Feb 25. pii: 10.1007/s10620-020-06164.
    PubMed     Abstract available


  136. CHARILAOU P, Devani K, Petrosyan R, Reddy C, et al
    Inpatient Mortality Benefit with Transjugular Intrahepatic Portosystemic Shunt for Hospitalized Hepatorenal Syndrome Patients.
    Dig Dis Sci. 2020 Feb 15. pii: 10.1007/s10620-020-06136.
    PubMed     Abstract available


  137. NEUBERGER J
    Liver Transplantation for Alcoholic Liver Disease: What Is the Risk and Consequence of Relapse?
    Dig Dis Sci. 2020 Feb 14. pii: 10.1007/s10620-020-06127.
    PubMed     Abstract available


  138. SINN DH, Lee HW, Paik YH, Kim DY, et al
    Patterns and Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Invasion: A Multicenter Prospective Cohort Study.
    Dig Dis Sci. 2020 Feb 13. pii: 10.1007/s10620-020-06134.
    PubMed     Abstract available


  139. RAMAI D, Ofosu A, Lai JK, Gao ZH, et al
    Fibrolamellar Hepatocellular Carcinoma: A Population-Based Observational Study.
    Dig Dis Sci. 2020 Feb 12. pii: 10.1007/s10620-020-06135.
    PubMed     Abstract available


    January 2020
  140. LEE EW, Lee AE, Saab S, Kee ST, et al
    Retrograde Transvenous Obliteration (RTO): A New Treatment Option for Hepatic Encephalopathy.
    Dig Dis Sci. 2020 Jan 31. pii: 10.1007/s10620-020-06050.
    PubMed     Abstract available


  141. MURPHY SL, Richardson JK, Blackwood J, Martinez B, et al
    Neurocognitive and Muscular Capacities Are Associated with Frailty in Adults with Cirrhosis.
    Dig Dis Sci. 2020 Jan 25. pii: 10.1007/s10620-020-06099.
    PubMed     Abstract available


  142. CHIANG RS, Parish A, Niedzwiecki D, Kappus MR, et al
    Impact of Malnutrition on Outcomes in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Insertion.
    Dig Dis Sci. 2020 Jan 21. pii: 10.1007/s10620-019-06038.
    PubMed     Abstract available


  143. SASSO R, Lauzon S, Rockey DC
    Cirrhotic Patients on Mechanical Ventilation Have a Low Rate of Successful Extubation and Survival.
    Dig Dis Sci. 2020 Jan 20. pii: 10.1007/s10620-020-06051.
    PubMed     Abstract available


  144. HO SY, Yuan MH, Chen CC, Liu PH, et al
    Differential Survival Impact of Diabetes Mellitus on Hepatocellular Carcinoma: Role of Staging Determinants.
    Dig Dis Sci. 2020 Jan 18. pii: 10.1007/s10620-020-06053.
    PubMed     Abstract available


  145. PERRY LM, Loehfelm T, Pillai R, Pan DY, et al
    Shifting the Treatment Paradigm for Pancreaticoportal Fistula Causing Hepatic Necrosis.
    Dig Dis Sci. 2020 Jan 9. pii: 10.1007/s10620-020-06045.
    PubMed    


  146. GUEDES RR, Kieling CO, Dos Santos JL, da Rocha C, et al
    Severity of Ascites Is Associated with Increased Mortality in Patients with Cirrhosis Secondary to Biliary Atresia.
    Dig Dis Sci. 2020 Jan 6. pii: 10.1007/s10620-019-06029.
    PubMed     Abstract available


  147. ZHAO XM, Zhang J, Liang YN, Niu YC, et al
    Astragaloside IV Synergizes with Ferulic Acid to Alleviate Hepatic Fibrosis in Bile Duct-Ligated Cirrhotic Rats.
    Dig Dis Sci. 2020 Jan 3. pii: 10.1007/s10620-019-06017.
    PubMed     Abstract available


  148. ALLEGRITTI M, Enrico B, Basile E, de Vito L, et al
    Non-cirrhotic Extra-Hepatic Porto-Systemic Shunt Causing Adult-Onset Encephalopathy Treated with Endovascular Closure.
    Dig Dis Sci. 2020 Jan 3. pii: 10.1007/s10620-019-06024.
    PubMed     Abstract available


  149. POLANCO NAP, McNally BB, Levy C, Carey EJ, et al
    Gender Differences in Hepatology Medical Literature.
    Dig Dis Sci. 2020 Jan 2. pii: 10.1007/s10620-019-06025.
    PubMed     Abstract available


  150. ENOMOTO M, Kawada N
    The Moral of Hepatic Fibrosis: Don't Always Believe Noninvasive Fibrosis Measurements.
    Dig Dis Sci. 2020 Jan 1. pii: 10.1007/s10620-019-06035.
    PubMed    


  151. LU J, Wang H, Zhang R, Wan Z, et al
    Effects of Photoperiod on Acetaminophen-Induced Hepatotoxicity in Mice.
    Dig Dis Sci. 2020;65:178-188.
    PubMed     Abstract available


  152. MILES DA, Levi CS, Uhanova J, Cuvelier S, et al
    Pocket-Sized Versus Conventional Ultrasound for Detecting Fatty Infiltration of the Liver.
    Dig Dis Sci. 2020;65:82-85.
    PubMed     Abstract available


    December 2019
  153. UNGER LW, Forstner B, Muckenhuber M, Scheuba K, et al
    Hepatic Steatosis in Lean Patients: Risk Factors and Impact on Mortality.
    Dig Dis Sci. 2019 Dec 24. pii: 10.1007/s10620-019-06000.
    PubMed     Abstract available


  154. CHEN W, Li K, Zhu K, Yan R, et al
    RP11-81H3.2 Acts as an Oncogene via microRNA-490-3p Inhibition and Consequential Tankyrase 2 Up-Regulation in Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Dec 19. pii: 10.1007/s10620-019-06007.
    PubMed     Abstract available


  155. WANG X, Luo X, Zhao M, Song J, et al
    Prognostic Factors for Acute Transjugular Intrahepatic Portosystemic Shunt Occlusion Using Expanded Polytetrafluoroethylene-Covered Stent.
    Dig Dis Sci. 2019 Dec 18. pii: 10.1007/s10620-019-06008.
    PubMed     Abstract available


  156. KAPS L, Grambihler A, Yemane B, Nagel M, et al
    Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC).
    Dig Dis Sci. 2019 Dec 18. pii: 10.1007/s10620-019-06009.
    PubMed     Abstract available


  157. MAHFOUZ M, Nguyen H, Tu J, Diaz CR, et al
    Knowledge and Perceptions of Hepatitis B and Hepatocellular Carcinoma Screening Guidelines Among Trainees: A Tale of Three Centers.
    Dig Dis Sci. 2019 Dec 7. pii: 10.1007/s10620-019-05980.
    PubMed     Abstract available


  158. YANG Y, Liu C, Qi L, Zhao T, et al
    Diagnosis of Pre-HCC Disease by Hepatobiliary-Specific Contrast-Enhanced Magnetic Resonance Imaging: A Review.
    Dig Dis Sci. 2019 Dec 5. pii: 10.1007/s10620-019-05981.
    PubMed     Abstract available


    November 2019
  159. CANNON MD, Martin P, Carrion AF
    Bacterial Infection in Patients with Cirrhosis: Don't Get Bugged to Death.
    Dig Dis Sci. 2019 Nov 25. pii: 10.1007/s10620-019-05943.
    PubMed     Abstract available


  160. OU HY, Cheng YF, Chuang YH, Hsu HW, et al
    Quantification of Functional MR Predicts Early Response in Post-doxorubicin Drug-Eluting Beads Chemoembolization for Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Nov 15. pii: 10.1007/s10620-019-05951.
    PubMed     Abstract available


  161. HSU PY, Hsu CT, Yeh ML, Huang CF, et al
    Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05938.
    PubMed     Abstract available


  162. GU C, Chai M, Liu J, Wang H, et al
    Expansion of Transdifferentiated Human Hepatocytes in a Serum-Free Microcarrier Culture System.
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05925.
    PubMed     Abstract available


  163. GOUDRA B, Singh PM
    GI Endoscopy Sedation in Patients with Cirrhosis: Routine or Unpredictable?
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05949.
    PubMed    


  164. VUYYURU SK, Singh AD, Gamanagatti SR, Rout G, et al
    A Randomized Control Trial of Thromboelastography-Guided Transfusion in Cirrhosis for High-Risk Invasive Liver-Related Procedures.
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05939.
    PubMed     Abstract available


  165. ZONG G, Xu Z, Zhang S, Shen Y, et al
    Retraction Note: CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.
    Dig Dis Sci. 2019 Nov 11. pii: 10.1007/s10620-019-05932.
    PubMed     Abstract available


  166. DEUTSCH-LINK S, Weinrieb RM, Jones LS, Solga SF, et al
    Prior Relapse, Ongoing Alcohol Consumption, and Failure to Engage in Treatment Predict Alcohol Relapse After Liver Transplantation.
    Dig Dis Sci. 2019 Nov 9. pii: 10.1007/s10620-019-05937.
    PubMed     Abstract available


  167. LIANG KH, Zhang P, Lin CL, Wang SC, et al
    Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients.
    Dig Dis Sci. 2019 Nov 2. pii: 10.1007/s10620-019-05915.
    PubMed     Abstract available


  168. SIMMONS OL, Meinzer C, Rule J, Lee WM, et al
    Liver Transplantation for Acetaminophen-Induced Acute Liver Failure: Role of Psychiatric Comorbidity in Listing Decisions and Outcomes.
    Dig Dis Sci. 2019 Nov 2. pii: 10.1007/s10620-019-05901.
    PubMed     Abstract available


    October 2019
  169. BIAN X, He X, Yang L, Wu W, et al
    Prognosis of Hepatocellular Carcinoma Among Cancer Survivors with Other Types of Primary Tumors.
    Dig Dis Sci. 2019 Oct 30. pii: 10.1007/s10620-019-05917.
    PubMed     Abstract available


  170. LING C, Khalid S, Martin D, Hanson J, et al
    HCCs and HCAs in Non-cirrhotic Patients: What You See May Not Be Enough.
    Dig Dis Sci. 2019 Oct 30. pii: 10.1007/s10620-019-05920.
    PubMed    


  171. HO SY, Liu PH, Hsu CY, Hsia CY, et al
    A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria.
    Dig Dis Sci. 2019 Oct 28. pii: 10.1007/s10620-019-05813.
    PubMed     Abstract available


  172. SCAGLIONE S, Adams W, Caines A, Devlin P, et al
    Association Between Race/Ethnicity and Insurance Status with Outcomes in Patients with Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Oct 23. pii: 10.1007/s10620-019-05890.
    PubMed     Abstract available


  173. MCCABE P, Galoosian A, Wong RJ
    Patients with Alcoholic Liver Disease Have Worse Functional Status at Time of Liver Transplant Registration and Greater Waitlist and Post-transplant Mortality Which Is Compounded by Older Age.
    Dig Dis Sci. 2019 Oct 22. pii: 10.1007/s10620-019-05891.
    PubMed     Abstract available


  174. STINE JG, Intagliata NM, Shah NL, Lisman T, et al
    Clinical Cirrhosis Dilemmas: Survey of Practice from the 7th International Coagulation in Liver Disease Conference.
    Dig Dis Sci. 2019 Oct 18. pii: 10.1007/s10620-019-05884.
    PubMed     Abstract available


  175. WANG JH, Ou HY, Yen YH, Chen CH, et al
    Usefulness of Controlled Attenuation Parameter in Detecting and Monitoring Hepatic Steatosis with MRI-PDFF as Reference.
    Dig Dis Sci. 2019 Oct 15. pii: 10.1007/s10620-019-05883.
    PubMed     Abstract available


  176. EDELSON J, Suarez AL, Zhang J, Rockey DC, et al
    Sedation During Endoscopy in Patients with Cirrhosis: Safety and Predictors of Adverse Events.
    Dig Dis Sci. 2019 Oct 12. pii: 10.1007/s10620-019-05845.
    PubMed     Abstract available


  177. ZOU B, Yeo YH, Jeong D, Park H, et al
    A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USA.
    Dig Dis Sci. 2019 Oct 9. pii: 10.1007/s10620-019-05869.
    PubMed     Abstract available


  178. WEN X, Ling S, Wu W, Shan Q, et al
    Ubiquitin-Specific Protease 22/Silent Information Regulator 1 Axis Plays a Pivotal Role in the Prognosis and 5-Fluorouracil Resistance in Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Oct 5. pii: 10.1007/s10620-019-05844.
    PubMed     Abstract available


    September 2019
  179. THOMSON MJ, Taylor A, Sharma P, Lok AS, et al
    Limited Progress in Hepatorenal Syndrome (HRS) Reversal and Survival 2002-2018: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2019 Sep 30. pii: 10.1007/s10620-019-05858.
    PubMed     Abstract available


  180. LI Y, Li Z, Jia Y, Ding B, et al
    In Vitro Anti-hepatoma Activities of Notoginsenoside R1 Through Downregulation of Tumor Promoter miR-21.
    Dig Dis Sci. 2019 Sep 26. pii: 10.1007/s10620-019-05856.
    PubMed     Abstract available


  181. KOOLA JD, Ho SB, Cao A, Chen G, et al
    Predicting 30-Day Hospital Readmission Risk in a National Cohort of Patients with Cirrhosis.
    Dig Dis Sci. 2019 Sep 17. pii: 10.1007/s10620-019-05826.
    PubMed     Abstract available


  182. GU S, Chen J, Zhou Q, Yan M, et al
    LRRK2 Is Associated with Recurrence-Free Survival in Intrahepatic Cholangiocarcinoma and Downregulation of LRRK2 Suppresses Tumor Progress In Vitro.
    Dig Dis Sci. 2019 Sep 5. pii: 10.1007/s10620-019-05806.
    PubMed     Abstract available


  183. GALOOSIAN A, Hanlon C, Tana M, Cheung R, et al
    Race/Ethnicity and Insurance-Specific Disparities in In-Hospital Mortality Among Adults with Primary Biliary Cholangitis: Analysis of 2007-2014 National Inpatient Sample.
    Dig Dis Sci. 2019 Sep 5. pii: 10.1007/s10620-019-05809.
    PubMed     Abstract available


  184. RAVAIOLI F, Colecchia A
    Sound Conclusions: How Splenic Elastography May Decrease the Need for Endoscopic Variceal Surveillance.
    Dig Dis Sci. 2019;64:2381-2383.
    PubMed    


  185. MA J, Qiu Y, Wang M, Zhang M, et al
    Locostatin Alleviates Liver Fibrosis Induced by Carbon Tetrachloride in Mice.
    Dig Dis Sci. 2019;64:2570-2580.
    PubMed     Abstract available


    August 2019
  186. ZHOU Y, Zhang Q, Kong Y, Guo X, et al
    Insulin-Like Growth Factor Binding Protein-Related Protein 1 Activates Primary Hepatic Stellate Cells via Autophagy Regulated by the PI3K/Akt/mTOR Signaling Pathway.
    Dig Dis Sci. 2019 Aug 29. pii: 10.1007/s10620-019-05798.
    PubMed     Abstract available


  187. SHERMAN KE, Abdel-Hameed EA, Ehman RL, Rouster SD, et al
    Validation and Refinement of Noninvasive Methods to Assess Hepatic Fibrosis: Magnetic Resonance Elastography Versus Enhanced Liver Fibrosis Index.
    Dig Dis Sci. 2019 Aug 29. pii: 10.1007/s10620-019-05815.
    PubMed     Abstract available


  188. WALLACE MC, Sek K, Francis RJ, Samuelson S, et al
    Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional Therapy.
    Dig Dis Sci. 2019 Aug 22. pii: 10.1007/s10620-019-05781.
    PubMed     Abstract available


  189. FEUERSTADT P, Hong SJ, Brandt LJ
    Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection.
    Dig Dis Sci. 2019 Aug 22. pii: 10.1007/s10620-019-05804.
    PubMed     Abstract available


  190. DONG Z, Liao B, Shen W, Sui C, et al
    Expression of Programmed Death Ligand 1 Is Associated with the Prognosis of Intrahepatic Cholangiocarcinoma.
    Dig Dis Sci. 2019 Aug 13. pii: 10.1007/s10620-019-05787.
    PubMed     Abstract available


  191. HAO YL, Bian ZL, Ju LL, Liu Y, et al
    RANK/RANKL Acts as a Protective Factor by Targeting Cholangiocytes in Primary Biliary Cholangitis.
    Dig Dis Sci. 2019 Aug 3. pii: 10.1007/s10620-019-05758.
    PubMed     Abstract available


  192. PHAW NA, Jones DEJ
    PBC: Better Solutions to Beat Feeling Beat.
    Dig Dis Sci. 2019;64:2075-2077.
    PubMed    


    July 2019
  193. COSTENTIN CE, Sogni P, Falissard B, Barbare JC, et al
    Geographical Disparities of Outcomes of Hepatocellular Carcinoma in France: The Heavier Burden of Alcohol Compared to Hepatitis C.
    Dig Dis Sci. 2019 Jul 25. pii: 10.1007/s10620-019-05724.
    PubMed     Abstract available


  194. TAO J, Li J, Chen X, Guo Y, et al
    Endoscopic Variceal Sequential Ligation Does Not Increase Risk of Gastroesophageal Reflux Disease in Cirrhosis Patients.
    Dig Dis Sci. 2019 Jul 22. pii: 10.1007/s10620-019-05740.
    PubMed     Abstract available


  195. SONG Q, Ren W, Fan L, Zhao M, et al
    Long-Term Outcomes of Transarterial Chemoembolization Combined with Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Recurrent Hepatocellular Carcinoma After Surgical Resection.
    Dig Dis Sci. 2019 Jul 17. pii: 10.1007/s10620-019-05733.
    PubMed     Abstract available


  196. SAMJI NS, Verma R, Keri KC, Singal AK, et al
    Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges.
    Dig Dis Sci. 2019 Jul 16. pii: 10.1007/s10620-019-05716.
    PubMed     Abstract available


  197. KUZNIETSOVA HM, Dziubenko NV, Lynchak OV, Herheliuk TS, et al
    Effects of Pristine C60 Fullerenes on Liver and Pancreas in alpha-Naphthylisothiocyanate-Induced Cholangitis.
    Dig Dis Sci. 2019 Jul 16. pii: 10.1007/s10620-019-05730.
    PubMed     Abstract available


  198. TUCKER RD, Ciofoaia V, Nadella S, Gay MD, et al
    A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Jul 11. pii: 10.1007/s10620-019-05722.
    PubMed     Abstract available


  199. TAPPER EB, Derstine B, Baki J, Su GL, et al
    Bedside Measures of Frailty and Cognitive Function Correlate with Sarcopenia in Patients with Cirrhosis.
    Dig Dis Sci. 2019 Jul 10. pii: 10.1007/s10620-019-05713.
    PubMed     Abstract available


  200. HAGSTROM H, Hemmingsson T, Discacciati A, Andreasson A, et al
    Risk Behaviors Associated with Alcohol Consumption Predict Future Severe Liver Disease.
    Dig Dis Sci. 2019;64:2014-2023.
    PubMed     Abstract available


    June 2019
  201. SEMMLER G, Stift J, Scheiner B, Woran K, et al
    Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension.
    Dig Dis Sci. 2019 Jun 17. pii: 10.1007/s10620-019-05702.
    PubMed     Abstract available


  202. SOMMARIVA C, Lauro A, Pagano N, Vaccari S, et al
    Subcapsular Hepatic Hematoma Post-ERCP: Case Report and Review of the Literature.
    Dig Dis Sci. 2019 Jun 13. pii: 10.1007/s10620-019-05679.
    PubMed     Abstract available


  203. KIM DS, Lim TS, Jeon MY, Kim BK, et al
    Transarterial Chemoembolization in Treatment-Naive and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis.
    Dig Dis Sci. 2019 Jun 11. pii: 10.1007/s10620-019-05701.
    PubMed     Abstract available


  204. MANKA P, Bechmann L, Best J, Sydor S, et al
    Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2019 Jun 3. pii: 10.1007/s10620-019-05687.
    PubMed     Abstract available


  205. CROPLEY A, Ashrafy AH, Weltman M
    An Original Description of Granulomatous Liver Cirrhosis in Blau Syndrome.
    Dig Dis Sci. 2019 Jun 1. pii: 10.1007/s10620-019-05682.
    PubMed    


  206. JENSEN CW, Worhunsky DJ, Triadafilopoulos G, Bingham DB, et al
    Ruptured Oncocytic Intraductal Papillary Neoplasm: Think Beyond the Pancreas.
    Dig Dis Sci. 2019;64:1436-1438.
    PubMed    


  207. LIU J, Li H, Sun L, Shen S, et al
    Epigenetic Alternations of MicroRNAs and DNA Methylation Contribute to Liver Metastasis of Colorectal Cancer.
    Dig Dis Sci. 2019;64:1523-1534.
    PubMed     Abstract available


    May 2019
  208. TU W, Gong J, Tian D, Wang Z, et al
    Hepatitis B Virus X Protein Induces SATB1 Expression Through Activation of ERK and p38MAPK Pathways to Suppress Anoikis.
    Dig Dis Sci. 2019 May 30. pii: 10.1007/s10620-019-05681.
    PubMed     Abstract available


  209. CORBI LE, Tannuri ACA, de Aro Braz MJ, Paes VR, et al
    Does Biliodigestive Anastomosis Have Any Effect on the Reversal of Hepatopulmonary Syndrome in a Biliary Cirrhosis Experimental Model?
    Dig Dis Sci. 2019 May 10. pii: 10.1007/s10620-019-05658.
    PubMed     Abstract available


  210. SIRAMOLPIWAT S, Punjachaipornpon T, Pornthisarn B, Vilaichone RK, et al
    N-Acetylcysteine Prevents Post-embolization Syndrome in Patients with Hepatocellular Carcinoma Following Transarterial Chemoembolization.
    Dig Dis Sci. 2019 May 9. pii: 10.1007/s10620-019-05652.
    PubMed     Abstract available


  211. ALMANZA D, Gharaee-Kermani M, Zhilin-Roth A, Rodriguez-Nieves JA, et al
    Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular Signature.
    Dig Dis Sci. 2019;64:1257-1269.
    PubMed     Abstract available


    April 2019
  212. LI X, Jiang F, Ge Z, Chen B, et al
    Fructose-Bisphosphate Aldolase A Regulates Hypoxic Adaptation in Hepatocellular Carcinoma and Involved with Tumor Malignancy.
    Dig Dis Sci. 2019 Apr 30. pii: 10.1007/s10620-019-05642.
    PubMed     Abstract available


  213. ZOU WY, Choi K, Kramer JR, Yu X, et al
    Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents.
    Dig Dis Sci. 2019 Apr 30. pii: 10.1007/s10620-019-05641.
    PubMed     Abstract available


  214. DEMORROW S
    Concise Commentary: Staying True to Type-The Increasing Inpatient Burden of Hepatic Encephalopathy.
    Dig Dis Sci. 2019 Apr 29. pii: 10.1007/s10620-019-05630.
    PubMed    


  215. KALANI A, Phan J, Taefi A, Deshmukh M, et al
    Necrotizing Pancreatitis: Common and Uncommon Sequelae and Solutions.
    Dig Dis Sci. 2019 Apr 27. pii: 10.1007/s10620-019-05634.
    PubMed    


  216. KARAGIANNAKIS DS, Voulgaris T, Koureta E, Chloupi E, et al
    Role of Spleen Stiffness Measurement by 2D-Shear Wave Elastography in Ruling Out the Presence of High-Risk Varices in Cirrhotic Patients.
    Dig Dis Sci. 2019 Apr 15. pii: 10.1007/s10620-019-05616.
    PubMed     Abstract available


  217. NAKATAKE R, Hishikawa H, Kotsuka M, Ishizaki M, et al
    The Proton Pump Inhibitor Lansoprazole Has Hepatoprotective Effects in In Vitro and In Vivo Rat Models of Acute Liver Injury.
    Dig Dis Sci. 2019 Apr 15. pii: 10.1007/s10620-019-05622.
    PubMed     Abstract available


  218. YU B, Ding Y, Liao X, Wang C, et al
    Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Apr 4. pii: 10.1007/s10620-019-05608.
    PubMed     Abstract available


  219. PILLAI A, Couri T, Charlton M
    Liver Allocation Policies in the USA: Past, Present, and the Future.
    Dig Dis Sci. 2019;64:985-992.
    PubMed     Abstract available


  220. GADSDEN MM, Kaplan DE
    Multidisciplinary Approach to HCC Management: How Can This Be Done?
    Dig Dis Sci. 2019;64:968-975.
    PubMed     Abstract available


  221. LANGE N, Dufour JF
    Changing Epidemiology of HCC: How to Screen and Identify Patients at Risk?
    Dig Dis Sci. 2019;64:903-909.
    PubMed     Abstract available


  222. BAILEY CW, Sydnor MK Jr
    Current State of Tumor Ablation Therapies.
    Dig Dis Sci. 2019;64:951-958.
    PubMed     Abstract available


  223. VOGL TJ, Gruber-Rouh T
    HCC: Transarterial Therapies-What the Interventional Radiologist Can Offer.
    Dig Dis Sci. 2019;64:959-967.
    PubMed     Abstract available


  224. SHERMAN M
    Design and Endpoints of Clinical Trials, Current and Future.
    Dig Dis Sci. 2019;64:1050-1057.
    PubMed     Abstract available


  225. FLOUDAS CS, Brar G, Greten TF
    Immunotherapy: Current Status and Future Perspectives.
    Dig Dis Sci. 2019;64:1030-1040.
    PubMed     Abstract available


  226. LONGERICH T, Schirmacher P
    Emerging Role of the Pathologist in Precision Medicine for HCC.
    Dig Dis Sci. 2019;64:928-933.
    PubMed    


    March 2019
  227. KOHLI R, Shingina A, New S, Chaturvedi S, et al
    Thromboelastography Parameters Are Associated with Cirrhosis Severity.
    Dig Dis Sci. 2019 Mar 26. pii: 10.1007/s10620-019-05597.
    PubMed     Abstract available


  228. YOON YI, Lee SG
    Living Donor Liver Transplantation for Hepatocellular Carcinoma: An Asian Perspective.
    Dig Dis Sci. 2019 Mar 20. pii: 10.1007/s10620-019-05551.
    PubMed     Abstract available


  229. SAFFO S, Taddei TH
    Systemic Management for Advanced Hepatocellular Carcinoma: A Review of the Molecular Pathways of Carcinogenesis, Current and Emerging Therapies, and Novel Treatment Strategies.
    Dig Dis Sci. 2019 Mar 18. pii: 10.1007/s10620-019-05582.
    PubMed     Abstract available


  230. LUO X, Liu Y, Ma S, Liu L, et al
    WDR34 Activates Wnt/Beta-Catenin Signaling in Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Mar 15. pii: 10.1007/s10620-019-05583.
    PubMed     Abstract available


  231. SONI PD, Palta M
    Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current State and Future Opportunities.
    Dig Dis Sci. 2019 Mar 14. pii: 10.1007/s10620-019-05539.
    PubMed     Abstract available


  232. WEI M, Ford J, Li Q, Jeong D, et al
    Correction to: Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.
    Dig Dis Sci. 2019 Mar 13. pii: 10.1007/s10620-019-05558.
    PubMed     Abstract available


  233. HIRODE G, Vittinghoff E, Wong RJ
    Increasing Burden of Hepatic Encephalopathy Among Hospitalized Adults: An Analysis of the 2010-2014 National Inpatient Sample.
    Dig Dis Sci. 2019 Mar 13. pii: 10.1007/s10620-019-05576.
    PubMed     Abstract available


  234. FUCHS M, Levy MF
    Introduction to the Emmet B. Keeffe, MD, Commemorative Special Issue on Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Mar 12. pii: 10.1007/s10620-019-05574.
    PubMed    


  235. SPOSITO C, Cucchetti A, Mazzaferro V
    Assessing Competing Risks for Death Following Liver Transplantation for Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Mar 9. pii: 10.1007/s10620-019-05538.
    PubMed     Abstract available


  236. NORONHA FERREIRA C, Reis D, Cortez-Pinto H, Tato Marinho R, et al
    Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Dig Dis Sci. 2019 Mar 9. pii: 10.1007/s10620-019-05572.
    PubMed     Abstract available


  237. KHAN RS, Newsome PN
    Fat and Fibrosis: Does Empagliflozin Impair the Progression of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus?
    Dig Dis Sci. 2019 Mar 7. pii: 10.1007/s10620-019-05573.
    PubMed    


  238. REICHMAN TW, Bhati CS, Battula NR
    Obtaining Optimal Long-Term Outcomes from Liver Transplantation for Hepatocellular Cancer.
    Dig Dis Sci. 2019 Mar 6. pii: 10.1007/s10620-019-05550.
    PubMed     Abstract available


  239. HARDING JJ, Khalil DN, Abou-Alfa GK
    Biomarkers: What Role Do They Play (If Any) for Diagnosis, Prognosis and Tumor Response Prediction for Hepatocellular Carcinoma?
    Dig Dis Sci. 2019 Mar 5. pii: 10.1007/s10620-019-05517.
    PubMed     Abstract available


  240. SAYINER M, Golabi P, Younossi ZM
    Disease Burden of Hepatocellular Carcinoma: A Global Perspective.
    Dig Dis Sci. 2019 Mar 5. pii: 10.1007/s10620-019-05537.
    PubMed     Abstract available


  241. ROUT G, Sharma S, Gunjan D, Kedia S, et al
    Development and Validation of a Novel Model for Outcomes in Patients with Cirrhosis and Acute Variceal Bleeding.
    Dig Dis Sci. 2019 Mar 4. pii: 10.1007/s10620-019-05557.
    PubMed     Abstract available


  242. MA L, Ishigami M, Honda T, Yokoyama S, et al
    Antifibrotic Effects of 1,25(OH)2D3 on Nonalcoholic Steatohepatitis in Female Mice.
    Dig Dis Sci. 2019 Mar 2. pii: 10.1007/s10620-019-05560.
    PubMed     Abstract available


  243. RONOT M, Purcell Y, Vilgrain V
    Hepatocellular Carcinoma: Current Imaging Modalities for Diagnosis and Prognosis.
    Dig Dis Sci. 2019 Mar 2. pii: 10.1007/s10620-019-05547.
    PubMed     Abstract available


  244. DISMUKE-GREER CE, Syn WK
    Coming Complications of Nonalcoholic Fatty Liver Disease: Time to GNASH Your Teeth.
    Dig Dis Sci. 2019;64:606-608.
    PubMed    


  245. ZHANG W, Chao S, Chen S, Rao H, et al
    Awareness and Knowledge of Nonalcoholic Fatty Liver Disease Among Office Employees in Beijing, China.
    Dig Dis Sci. 2019;64:708-717.
    PubMed     Abstract available


  246. MANTOVANI A
    Nonalcoholic Fatty Liver Disease and Bone Mineral Density in Children and Adolescents: Specific Considerations for Future Studies.
    Dig Dis Sci. 2019;64:898-900.
    PubMed    


  247. KANG HT, Jun DW, Jang K, Hoh JK, et al
    Effect of Stem Cell Treatment on Acute Liver Failure Model Using Scaffold.
    Dig Dis Sci. 2019;64:781-791.
    PubMed     Abstract available


  248. NGUYEN AL, Park H, Nguyen P, Sheen E, et al
    Rising Inpatient Encounters and Economic Burden for Patients with Nonalcoholic Fatty Liver Disease in the USA.
    Dig Dis Sci. 2019;64:698-707.
    PubMed     Abstract available


    February 2019
  249. JIAN ZW, Wu XW, Chen ZX, Wang JC, et al
    Effect of Nucleos(t)ide Analogs on Patients with Intermediate and Advanced Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Feb 28. pii: 10.1007/s10620-019-05543.
    PubMed     Abstract available


  250. XIAO Y, Zhang S, Li Q, Liu Z, et al
    miR-219a-5p Ameliorates Hepatic Ischemia/Reperfusion Injury via Impairing TP53BP2.
    Dig Dis Sci. 2019 Feb 22. pii: 10.1007/s10620-019-05535.
    PubMed     Abstract available


  251. ARDOLINO E, Wang SS, Patwardhan VR
    Evidence of Significant Ceftriaxone and Quinolone Resistance in Cirrhotics with Spontaneous Bacterial Peritonitis.
    Dig Dis Sci. 2019 Feb 14. pii: 10.1007/s10620-019-05519.
    PubMed     Abstract available


  252. ZHAO J, Xu H, Li Y, Gong L, et al
    NAFLD Induction Delays Postoperative Liver Regeneration of ALPPS in Rats.
    Dig Dis Sci. 2019;64:456-468.
    PubMed     Abstract available


  253. XI L, Zhu J, Zhang H, Muktiali M, et al
    Epidemiological Trends in Gastrointestinal Cancers in China: An Ecological Study.
    Dig Dis Sci. 2019;64:532-543.
    PubMed     Abstract available


    January 2019
  254. NEVENS F, Bittencourt PL, Coenraad MJ, Ding H, et al
    Recommendations on the Diagnosis and Initial Management of Acute Variceal Bleeding and Hepatorenal Syndrome in Patients with Cirrhosis.
    Dig Dis Sci. 2019 Jan 25. pii: 10.1007/s10620-018-5448.
    PubMed     Abstract available


  255. LAI LL, Vethakkan SR, Nik Mustapha NR, Mahadeva S, et al
    Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus.
    Dig Dis Sci. 2019 Jan 25. pii: 10.1007/s10620-019-5477.
    PubMed     Abstract available


  256. BARRITT AS 4TH, Jiang Y, Schmidt M, Hayashi PH, et al
    Charges for Alcoholic Cirrhosis Exceed All Other Etiologies of Cirrhosis Combined: A National and State Inpatient Survey Analysis.
    Dig Dis Sci. 2019 Jan 23. pii: 10.1007/s10620-019-5471.
    PubMed     Abstract available


  257. TANSEL A, Kramer J, Feng H, El-Serag HB, et al
    Risk Trajectories for Readmission and Death After Cirrhosis-Related Hospitalization.
    Dig Dis Sci. 2019 Jan 23. pii: 10.1007/s10620-019-5459.
    PubMed     Abstract available


  258. ZHI SC, Chen SZ, Li YY, Li JJ, et al
    Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis.
    Dig Dis Sci. 2019 Jan 23. pii: 10.1007/s10620-019-5462.
    PubMed     Abstract available


  259. THEOCHARIDOU E, Giouleme O, Anastasiadis S, Markopoulou A, et al
    Free Cortisol Is a More Accurate Marker for Adrenal Function and Does Not Correlate with Renal Function in Cirrhosis.
    Dig Dis Sci. 2019 Jan 19. pii: 10.1007/s10620-019-5460.
    PubMed     Abstract available


  260. BERNARDI N, Chedid MF, Grezzana-Filho TJM, Chedid AD, et al
    Pre-transplant ALBI Grade 3 Is Associated with Increased Mortality After Liver Transplantation.
    Dig Dis Sci. 2019 Jan 14. pii: 10.1007/s10620-019-5456.
    PubMed     Abstract available


  261. WANG S, Liang C, Ai H, Yang M, et al
    Hepatic miR-181b-5p Contributes to Glycogen Synthesis Through Targeting EGR1.
    Dig Dis Sci. 2019 Jan 9. pii: 10.1007/s10620-018-5442.
    PubMed     Abstract available


  262. DAKHOUL L, Jones KR, Gawrieh S, Ghabril M, et al
    Older Age and Disease Duration Are Highly Associated with Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
    Dig Dis Sci. 2019 Jan 7. pii: 10.1007/s10620-018-5441.
    PubMed     Abstract available


  263. LEE KC, Hsu WF, Hsieh YC, Chan CC, et al
    Dabigatran Reduces Liver Fibrosis in Thioacetamide-Injured Rats.
    Dig Dis Sci. 2019;64:102-112.
    PubMed     Abstract available


  264. JIAO Y, Li Y, Lu Z, Liu Y, et al
    High Trophinin-Associated Protein Expression Is an Independent Predictor of Poor Survival in Liver Cancer.
    Dig Dis Sci. 2019;64:137-143.
    PubMed     Abstract available


  265. JIN X, Zimmers TA, Zhang Z, Koniaris LG, et al
    Resveratrol Improves Recovery and Survival of Diet-Induced Obese Mice Undergoing Extended Major (80%) Hepatectomy.
    Dig Dis Sci. 2019;64:93-101.
    PubMed     Abstract available


  266. ROSENBLATT R, Mehta A, Snell D, Hissong E, et al
    Ultrasonographic Nonalcoholic Fatty Pancreas Is Associated with Advanced Fibrosis in NAFLD: A Retrospective Analysis.
    Dig Dis Sci. 2019;64:262-268.
    PubMed     Abstract available


  267. LI P, Shan K, Liu Y, Zhang Y, et al
    CircScd1 Promotes Fatty Liver Disease via the Janus Kinase 2/Signal Transducer and Activator of Transcription 5 Pathway.
    Dig Dis Sci. 2019;64:113-122.
    PubMed     Abstract available


    December 2018
  268. STINE JG, Northup PG
    Management of Non-tumoral Portal Vein Thrombosis in Patients with Cirrhosis.
    Dig Dis Sci. 2018 Dec 17. pii: 10.1007/s10620-018-5427.
    PubMed     Abstract available


  269. KAKAR S, Dugum M, Cabello R, Humar A, et al
    Incidence of Recurrent NASH-Related Allograft Cirrhosis.
    Dig Dis Sci. 2018 Dec 17. pii: 10.1007/s10620-018-5413.
    PubMed     Abstract available


  270. MAIMONE S, Saffioti F, Filomia R, Alibrandi A, et al
    Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS).
    Dig Dis Sci. 2018 Dec 17. pii: 10.1007/s10620-018-5412.
    PubMed     Abstract available


  271. HUANG X, Gao Y, Qin J, Lu S, et al
    miR-214 Down-Regulation Promoted Hypoxia/Reoxygenation-Induced Hepatocyte Apoptosis Through TRAF1/ASK1/JNK Pathway.
    Dig Dis Sci. 2018 Dec 17. pii: 10.1007/s10620-018-5405.
    PubMed     Abstract available


  272. PINERO F, Rubinstein F, Marciano S, Fernandez N, et al
    Surveillance for Hepatocellular Carcinoma: Does the Place Where Ultrasound Is Performed Impact Its Effectiveness?
    Dig Dis Sci. 2018 Dec 3. pii: 10.1007/s10620-018-5390.
    PubMed     Abstract available


  273. TOLBOL KS, Stierstorfer B, Rippmann JF, Veidal SS, et al
    Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2018 Dec 3. pii: 10.1007/s10620-018-5395.
    PubMed     Abstract available


  274. SHETTY A, Hsu JW, Manka PP, Syn WK, et al
    Role of the Circadian Clock in the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2018;63:3187-3206.
    PubMed     Abstract available


    November 2018
  275. MATSUURA Y, Wada H, Eguchi H, Gotoh K, et al
    Exosomal miR-155 Derived from Hepatocellular Carcinoma Cells Under Hypoxia Promotes Angiogenesis in Endothelial Cells.
    Dig Dis Sci. 2018 Nov 22. pii: 10.1007/s10620-018-5380.
    PubMed     Abstract available


  276. WANG B, Zhao KL, Hu WJ, Zuo T, et al
    Macrophage Migration Inhibitor Promoted the Intrahepatic Bile Duct Injury in Rats with Severe Acute Pancreatitis.
    Dig Dis Sci. 2018 Nov 22. pii: 10.1007/s10620-018-5379.
    PubMed     Abstract available


  277. JARA M, Dziodzio T, Malinowski M, Luttgert K, et al
    Prospective Assessment of Liver Function by an Enzymatic Liver Function Test to Estimate Short-Term Survival in Patients with Liver Cirrhosis.
    Dig Dis Sci. 2018 Nov 7. pii: 10.1007/s10620-018-5360.
    PubMed     Abstract available


  278. DE MARIA C, Ghidotti I, Grillo F, Giannini EG, et al
    Successful DAA Treatment and Global Improvement in a Cirrhotic Patient with Concomitant HCV Infection and Autoimmune Hepatitis.
    Dig Dis Sci. 2018 Nov 1. pii: 10.1007/s10620-018-5356.
    PubMed    


    October 2018
  279. MURPHY SL, Tapper EB, Blackwood J, Richardson JK, et al
    Why Do Individuals with Cirrhosis Fall? A Mechanistic Model for Fall Assessment, Treatment, and Research.
    Dig Dis Sci. 2018 Oct 16. pii: 10.1007/s10620-018-5333.
    PubMed     Abstract available


  280. LIEW ZH, Goh GB, Hao Y, Chang PE, et al
    Comparison of Hepatocellular Carcinoma in Patients with Cryptogenic Versus Hepatitis B Etiology: A Study of 1079 Cases Over 3 Decades.
    Dig Dis Sci. 2018 Oct 16. pii: 10.1007/s10620-018-5331.
    PubMed     Abstract available


  281. CHO SY, Kim S, Son MJ, Rou WS, et al
    Clinical Significance of the Thioredoxin System and Thioredoxin-Domain-Containing Protein Family in Hepatocellular Carcinoma.
    Dig Dis Sci. 2018 Oct 4. pii: 10.1007/s10620-018-5307.
    PubMed     Abstract available


    September 2018
  282. KORNBERG A, Schernhammer M, Kornberg J, Friess H, et al
    Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma.
    Dig Dis Sci. 2018 Sep 27. pii: 10.1007/s10620-018-5296.
    PubMed     Abstract available


  283. YANNY B, Saab S, Durazo F, Latt N, et al
    Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naive Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mL.
    Dig Dis Sci. 2018 Sep 27. pii: 10.1007/s10620-018-5283.
    PubMed     Abstract available


  284. OU Q, Weng Y, Wang S, Zhao Y, et al
    Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-kappaB Pathway.
    Dig Dis Sci. 2018 Sep 6. pii: 10.1007/s10620-018-5268.
    PubMed     Abstract available


  285. CHASCSA DM, Lai JC, Dunn MA, Montano-Loza AJ, et al
    Patient and Caregiver Attitudes and Practices of Exercise in Candidates Listed for Liver Transplantation.
    Dig Dis Sci. 2018 Sep 3. pii: 10.1007/s10620-018-5271.
    PubMed     Abstract available


  286. CAO LL, Pei XF, Qiao X, Yu J, et al
    SERPINA3 Silencing Inhibits the Migration, Invasion, and Liver Metastasis of Colon Cancer Cells.
    Dig Dis Sci. 2018;63:2309-2319.
    PubMed     Abstract available


  287. PATEL YA, Gifford EJ, Glass LM, Turner MJ, et al
    Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Dig Dis Sci. 2018;63:2259-2266.
    PubMed     Abstract available


    August 2018
  288. KIM HJ, Kang TU, Swan H, Kang MJ, et al
    Incidence and Prognosis of Subsequent Cholangiocarcinoma in Patients with Hepatic Resection for Bile Duct Stones.
    Dig Dis Sci. 2018 Aug 31. pii: 10.1007/s10620-018-5262.
    PubMed     Abstract available


  289. ADDEPALLY NS, George N, Martinez-Macias R, Garcia-Saenz-de-Sicilia M, et al
    Hemoglobin A1c Has Suboptimal Performance to Diagnose and Monitor Diabetes Mellitus in Patients with Cirrhosis.
    Dig Dis Sci. 2018 Aug 29. pii: 10.1007/s10620-018-5265.
    PubMed     Abstract available


  290. ZHANG G, Yu X, Liu P, Huang X, et al
    Efficacy of Nucleoside Analogs for Chronic Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Treatment: A Meta-Analysis.
    Dig Dis Sci. 2018 Aug 23. pii: 10.1007/s10620-018-5252.
    PubMed     Abstract available


    July 2018
  291. KALIANNAN K
    Compromise of alpha-Defensin Function in Liver Cirrhosis Facilitates the Toxic Relationship Between Gut Permeability and Endotoxemia.
    Dig Dis Sci. 2018 Jul 14. pii: 10.1007/s10620-018-5197.
    PubMed    


  292. SORENSEN M, Larsen LP, Villadsen GE, Aagaard NK, et al
    beta-Blockers Improve Presinusoidal Portal Hypertension.
    Dig Dis Sci. 2018 Jul 12. pii: 10.1007/s10620-018-5186.
    PubMed     Abstract available


  293. LING C, Gavin M, Hanson J, McCarthy DM, et al
    Progressive Epigastric Pain with Abnormal Liver Tests in a Patient with Crohn's Disease: Don't DILI Dally.
    Dig Dis Sci. 2018;63:1751-1755.
    PubMed    


  294. MANTOVANI A, Grani G
    Thyroid Dysfunction and Nonalcoholic Fatty Liver Disease: We Need New Larger and Well-Designed Longitudinal Studies.
    Dig Dis Sci. 2018;63:1970-1976.
    PubMed    


    June 2018
  295. ZHANG S, Gong Y, Xiao J, Chai Y, et al
    A COL1A1 Promoter-Controlled Expression of TGF-beta Soluble Receptor Inhibits Hepatic Fibrosis Without Triggering Autoimmune Responses.
    Dig Dis Sci. 2018 Jun 23. pii: 10.1007/s10620-018-5168.
    PubMed     Abstract available


  296. LENHART A, Hussain S, Salgia R
    Chances of Renal Recovery or Liver Transplantation After Hospitalization for Alcoholic Liver Disease Requiring Dialysis.
    Dig Dis Sci. 2018 Jun 22. pii: 10.1007/s10620-018-5170.
    PubMed     Abstract available


  297. OU H, Huang Y, Xiang L, Chen Z, et al
    Circulating Tumor Cell Phenotype Indicates Poor Survival and Recurrence After Surgery for Hepatocellular Carcinoma.
    Dig Dis Sci. 2018 Jun 21. pii: 10.1007/s10620-018-5124.
    PubMed     Abstract available


  298. TSIAOUSSIS GI, Papaioannou EC, Kourea EP, Assimakopoulos SF, et al
    Expression of alpha-Defensins, CD20+ B-lymphocytes, and Intraepithelial CD3+ T-lymphocytes in the Intestinal Mucosa of Patients with Liver Cirrhosis: Emerging Mediators of Intestinal Barrier Function.
    Dig Dis Sci. 2018 Jun 7. pii: 10.1007/s10620-018-5146.
    PubMed     Abstract available


  299. KOK B, Lester ELW, Lee WM, Hanje AJ, et al
    Acute Liver Failure from Tumor Necrosis Factor-alpha Antagonists: Report of Four Cases and Literature Review.
    Dig Dis Sci. 2018;63:1654-1666.
    PubMed     Abstract available


    May 2018
  300. BAJAJ JS, Ross D
    Concise Commentary: Remaining Outside the Hospital Is a Golden State in Cirrhosis-Lessons from California.
    Dig Dis Sci. 2018 May 30. pii: 10.1007/s10620-018-5134.
    PubMed    


  301. WALLACE MC, Knuiman M, Huang Y, Garas G, et al
    The Prognostic Ability of Major Hepatocellular Carcinoma Staging Systems Is Improved by Including a Treatment Variable.
    Dig Dis Sci. 2018 May 28. pii: 10.1007/s10620-018-5132.
    PubMed     Abstract available


  302. JOPSON L, Khanna A, Peterson P, Rudell E, et al
    Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness.
    Dig Dis Sci. 2018 May 8. pii: 10.1007/s10620-018-5074.
    PubMed     Abstract available


  303. SHEN J, Liu J, Li C, Wen T, et al
    The Impact of Tumor Differentiation on the Prognosis of HBV-Associated Solitary Hepatocellular Carcinoma Following Hepatectomy: A Propensity Score Matching Analysis.
    Dig Dis Sci. 2018 May 7. pii: 10.1007/s10620-018-5077.
    PubMed     Abstract available


  304. WANG P, Li Z, Ren S, Li J, et al
    Spleen Regulates Hematopoietic Stem/Progenitor Cell Functions Through Regulation of EGF in Cirrhotic Hypersplenism.
    Dig Dis Sci. 2018 May 3. pii: 10.1007/s10620-018-5091.
    PubMed     Abstract available


  305. FACCIORUSSO A, Roy S, Livadas S, Fevrier-Paul A, et al
    Nonselective Beta-Blockers Do Not Affect Survival in Cirrhotic Patients with Ascites.
    Dig Dis Sci. 2018 May 3. pii: 10.1007/s10620-018-5092.
    PubMed     Abstract available


  306. ROTH CG, Marzio DH, Guglielmo FF
    Contributions of Magnetic Resonance Imaging to Gastroenterological Practice: MRIs for GIs.
    Dig Dis Sci. 2018;63:1102-1122.
    PubMed     Abstract available


  307. KAUNITZ JD
    Magnetic Resonance Imaging: The Nuclear Option.
    Dig Dis Sci. 2018;63:1100-1101.
    PubMed    


  308. NIU B, Kim B, Limketkai BN, Sun J, et al
    Mortality from Spontaneous Bacterial Peritonitis Among Hospitalized Patients in the USA.
    Dig Dis Sci. 2018;63:1327-1333.
    PubMed     Abstract available


    April 2018
  309. GARCIA-RODRIGUEZ MT, Pertega-Diaz S, Lopez-Calvino B, Pinon-Villar MDC, et al
    Nomogram and Validity of a Model for Predicting Malnutrition in Patients on Liver Transplant Lists.
    Dig Dis Sci. 2018 Apr 25. pii: 10.1007/s10620-018-5079.
    PubMed     Abstract available


  310. ILAN Y
    Future of Treatment for Nonalcoholic Steatohepatitis: Can the Use of Safe, Evidence-Based, Clinically Proven Supplements Provide the Answer to the Unmet Need?
    Dig Dis Sci. 2018 Apr 20. pii: 10.1007/s10620-018-5080.
    PubMed     Abstract available


  311. SAFADI S, Delu AN, Alcorn J, McCarthy D, et al
    Portal Hypertensive Bleeding: A Navel Approach.
    Dig Dis Sci. 2018 Apr 19. pii: 10.1007/s10620-018-5062.
    PubMed    


  312. GIANNINI EG, Coppo C, Romana C, Camerini GB, et al
    Long-Term Follow-Up Study of Liver-Related Outcome After Bilio-Pancreatic Diversion in Patients with Initial, Significant Liver Damage.
    Dig Dis Sci. 2018 Apr 9. pii: 10.1007/s10620-018-5052.
    PubMed     Abstract available


  313. GADIPARTHI C, Cholankeril G, Yoo ER, Hu M, et al
    Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Dig Dis Sci. 2018 Apr 2. pii: 10.1007/s10620-018-5032.
    PubMed     Abstract available


    March 2018
  314. PONZETTO A, Vaira D
    Hepatic Encephalopathy and Helicobacter pylori.
    Dig Dis Sci. 2018 Mar 29. pii: 10.1007/s10620-018-5038.
    PubMed    


  315. DANIELSEN KV, Wiese S, Hove J, Bendtsen F, et al
    Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival?
    Dig Dis Sci. 2018 Mar 8. pii: 10.1007/s10620-018-5006.
    PubMed     Abstract available


  316. ZOU WY, El-Serag HB, Sada YH, Temple SL, et al
    Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population.
    Dig Dis Sci. 2018 Mar 5. pii: 10.1007/s10620-018-4989.
    PubMed     Abstract available


  317. GREMIDA A, Paleti S, Perez ET, McCarthy D, et al
    Hemolysis in Alcoholic Liver Disease: Zieve's Syndrome.
    Dig Dis Sci. 2018;63:601-604.
    PubMed    


    February 2018
  318. VARDI I, Barel O, Sperber M, Schvimer M, et al
    Genetic and Structural Analysis of a SKIV2L Mutation Causing Tricho-hepato-enteric Syndrome.
    Dig Dis Sci. 2018 Feb 26. pii: 10.1007/s10620-018-4983.
    PubMed     Abstract available


  319. KOUNTOURAS J, Polyzos SA, Katsinelos P, Anastasiadis S, et al
    Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology.
    Dig Dis Sci. 2018 Feb 21. pii: 10.1007/s10620-018-4911.
    PubMed    


  320. WEI M, Ford J, Li Q, Jeong D, et al
    Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.
    Dig Dis Sci. 2018 Feb 19. pii: 10.1007/s10620-018-4964.
    PubMed     Abstract available


  321. MAIER MM, Zhou XH, Chapko M, Leipertz SL, et al
    Hepatitis C Cure Is Associated with Decreased Healthcare Costs in Cirrhotics in Retrospective Veterans Affairs Cohort.
    Dig Dis Sci. 2018 Feb 16. pii: 10.1007/s10620-018-4956.
    PubMed     Abstract available


  322. KIM JH, Sinn DH, Lee JH, Hyun D, et al
    Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization.
    Dig Dis Sci. 2018 Feb 13. pii: 10.1007/s10620-018-4934.
    PubMed     Abstract available


  323. YU Z, Wang R, Chen F, Wang J, et al
    Five Novel Oncogenic Signatures Could Be Utilized as AFP-Related Diagnostic Biomarkers for Hepatocellular Carcinoma Based on Next-Generation Sequencing.
    Dig Dis Sci. 2018 Feb 13. pii: 10.1007/s10620-018-4961.
    PubMed     Abstract available


  324. MINDIKOGLU AL, Opekun AR, Mitch WE, Magder LS, et al
    Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis.
    Dig Dis Sci. 2018 Feb 1. pii: 10.1007/s10620-017-4897.
    PubMed     Abstract available


  325. ESCORSELL A, Garcia-Pagan JC, Bosch J
    Esophageal Stents for Acute Variceal Bleeding: Expanding the Possibilities.
    Dig Dis Sci. 2018;63:275-276.
    PubMed    


  326. MAIWALL R, Jamwal KD, Bhardwaj A, Bhadoria AS, et al
    SX-Ella Stent Danis Effectively Controls Refractory Variceal Bleed in Patients with Acute-on-Chronic Liver Failure.
    Dig Dis Sci. 2018;63:493-501.
    PubMed     Abstract available


    January 2018
  327. TORRES-MENA JE, Salazar-Villegas KN, Sanchez-Rodriguez R, Lopez-Gabino B, et al
    Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
    Dig Dis Sci. 2018 Jan 30. pii: 10.1007/s10620-018-4943.
    PubMed     Abstract available


  328. BAFFY G
    Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2018 Jan 22. pii: 10.1007/s10620-017-4903.
    PubMed     Abstract available


  329. NG PKS, Lau CPY, Lam EKY, Li SSK, et al
    Hypermethylation of NF-kappaB-Activating Protein-Like (NKAPL) Promoter in Hepatocellular Carcinoma Suppresses Its Expression and Predicts a Poor Prognosis.
    Dig Dis Sci. 2018 Jan 20. pii: 10.1007/s10620-018-4929.
    PubMed     Abstract available


  330. BENBOW JH, Elam AD, Bossi KL, Massengill DL, et al
    Analysis of Plasma Tenascin-C in Post-HCV Cirrhosis: A Prospective Study.
    Dig Dis Sci. 2018 Jan 12. pii: 10.1007/s10620-017-4860.
    PubMed     Abstract available


  331. BURROUGHS TK, Wade JB, Ellwood MS, Fagan A, et al
    Effect of Post-Traumatic Stress Disorder on Cognitive Function and Covert Hepatic Encephalopathy Diagnosis in Cirrhotic Veterans.
    Dig Dis Sci. 2018 Jan 8. pii: 10.1007/s10620-017-4894.
    PubMed     Abstract available


  332. LI S, He X, Dang L, Xu F, et al
    Efficacy of (125)I Versus Non-(125)I Combined with Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma with Obstructive Jaundice.
    Dig Dis Sci. 2018 Jan 5. pii: 10.1007/s10620-017-4899.
    PubMed     Abstract available


    December 2017
  333. CHOE WH, Kim JH, Park JH, Kim HU, et al
    Endoscopic Submucosal Dissection of Early Gastric Cancer in Patients with Liver Cirrhosis.
    Dig Dis Sci. 2017 Dec 27. pii: 10.1007/s10620-017-4814.
    PubMed     Abstract available


  334. JONES PD, Diaz C, Wang D, Gonzalez-Diaz J, et al
    The Impact of Race on Survival After Hepatocellular Carcinoma in a Diverse American Population.
    Dig Dis Sci. 2017 Dec 23. pii: 10.1007/s10620-017-4869.
    PubMed     Abstract available


  335. ZHANG X, Li C, Wen T, Peng W, et al
    Outcomes of Salvage Liver Transplantation and Re-resection/Radiofrequency Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma: A New Surgical Strategy Based on Recurrence Pattern.
    Dig Dis Sci. 2017 Dec 14. pii: 10.1007/s10620-017-4861.
    PubMed     Abstract available


  336. LIN M, Chang Y, Xie F, Shi Y, et al
    ASPP2 Inhibits the Profibrotic Effects of Transforming Growth Factor-beta1 in Hepatic Stellate Cells by Reducing Autophagy.
    Dig Dis Sci. 2017 Dec 2. pii: 10.1007/s10620-017-4816.
    PubMed     Abstract available


  337. SUK KT, Kim MY, Jeong SW, Jang JY, et al
    Impact of Bacterial Translocation on Hepatopulmonary Syndrome: A Prospective Observational Study.
    Dig Dis Sci. 2017 Dec 1. pii: 10.1007/s10620-017-4868.
    PubMed     Abstract available


  338. AHMAD J, Odin JA, Hayashi PH, Chalasani N, et al
    Identification and Characterization of Fenofibrate-Induced Liver Injury.
    Dig Dis Sci. 2017;62:3596-3604.
    PubMed     Abstract available


  339. YANG HJ, Chang Y, Park SK, Jung YS, et al
    Nonalcoholic Fatty Liver Disease Is Associated with Increased Risk of Reflux Esophagitis.
    Dig Dis Sci. 2017;62:3605-3613.
    PubMed     Abstract available


  340. GLASS LM, Waljee AK, McCurdy H, Su GL, et al
    Specialty Care Access Network-Extension of Community Healthcare Outcomes Model Program for Liver Disease Improves Specialty Care Access.
    Dig Dis Sci. 2017;62:3344-3349.
    PubMed     Abstract available


    November 2017
  341. LIU H, Hu J, Pan H, Luo D, et al
    CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing beta-Catenin Ubiquitination.
    Dig Dis Sci. 2017 Nov 30. pii: 10.1007/s10620-017-4855.
    PubMed     Abstract available


  342. GANDINI R, Merolla S, Chegai F, Abrignani S, et al
    Trans-splenic Embolization Plus Partial Splenic Embolization for Management of Variceal Bleeding Due to Left-Sided Portal Hypertension.
    Dig Dis Sci. 2017 Nov 28. pii: 10.1007/s10620-017-4863.
    PubMed    


  343. PRIVITERA G, Spadaro L, Marchisello S, Fede G, et al
    Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.
    Dig Dis Sci. 2017 Nov 25. pii: 10.1007/s10620-017-4862.
    PubMed     Abstract available


  344. ZHOU C, Sun Y, Guo S, Chen X, et al
    Wls Expression Correlates with Tumor Differentiation and TNM Stage in Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Nov 10. doi: 10.1007/s10620-017-4823.
    PubMed     Abstract available


  345. TITAN AL, Devereaux K, Louie JD, Poultsides GA, et al
    Clinical Trigonometry: Right Hepatic Trisegmentectomy After Radiation Trisegmentectomy for Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Nov 8. doi: 10.1007/s10620-017-4797.
    PubMed    


  346. WIJARNPREECHA K, Chesdachai S, Thongprayoon C, Jaruvongvanich V, et al
    Association of Helicobacter pylori with the Risk of Hepatic Encephalopathy.
    Dig Dis Sci. 2017 Nov 8. doi: 10.1007/s10620-017-4834.
    PubMed     Abstract available


  347. HUANG CS, Zhai JM, Zhu XX, Cai JP, et al
    BTG2 Is Down-Regulated and Inhibits Cancer Stem Cell-Like Features of Side Population Cells in Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Nov 2. doi: 10.1007/s10620-017-4829.
    PubMed     Abstract available


  348. CULLARO G, Kim G, Pereira MR, Brown RS Jr, et al
    Ascites Neutrophil Gelatinase-Associated Lipocalin Identifies Spontaneous Bacterial Peritonitis and Predicts Mortality in Hospitalized Patients with Cirrhosis.
    Dig Dis Sci. 2017 Nov 2. doi: 10.1007/s10620-017-4804.
    PubMed     Abstract available


  349. TANEJA S, Borkakoty A, Rathi S, Kumar V, et al
    Assessment of Liver Fibrosis by Transient Elastography Should Be Done After Hemodialysis in End Stage Renal Disease Patients with Liver Disease.
    Dig Dis Sci. 2017;62:3186-3192.
    PubMed     Abstract available


  350. CATRON TD, Smallfield GB, Kang L, Sterling RK, et al
    Endoscopic Cyanoacrylate Injection with Post-injection Audible Doppler Assessment of Gastric Varices: A Single-Institution Experience.
    Dig Dis Sci. 2017;62:3091-3099.
    PubMed     Abstract available


    October 2017
  351. LU Z, Lin Y, Peng B, Bao Z, et al
    Hydrogen-Rich Saline Ameliorates Hepatic Ischemia-Reperfusion Injury Through Regulation of Endoplasmic Reticulum Stress and Apoptosis.
    Dig Dis Sci. 2017 Oct 30. doi: 10.1007/s10620-017-4811.
    PubMed     Abstract available


  352. MUDAMBI K, Berquist W
    "Blueberry Muffin" Rash and Neonatal Cholestatic Liver Failure.
    Dig Dis Sci. 2017 Oct 25. doi: 10.1007/s10620-017-4810.
    PubMed    


  353. WU W, Liu S, Liang Y, Zhou Z, et al
    Stress Hormone Cortisol Enhances Bcl2 Like-12 Expression to Inhibit p53 in Hepatocellular Carcinoma Cells.
    Dig Dis Sci. 2017 Oct 17. doi: 10.1007/s10620-017-4798.
    PubMed     Abstract available


  354. KIM JK, Kim HD, Jun MJ, Yun SC, et al
    Correction to: Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Oct 13. doi: 10.1007/s10620-017-4785.
    PubMed     Abstract available


  355. KRUGER AJ, Mumtaz K, Anaizi A, Modi RM, et al
    Cirrhosis Is Associated with Increased Mortality in Patients with Diverticulitis: A Nationwide Cross-Sectional Study.
    Dig Dis Sci. 2017 Oct 6. doi: 10.1007/s10620-017-4782.
    PubMed     Abstract available


  356. OH IS, Sinn DH, Kang TW, Lee MW, et al
    Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
    Dig Dis Sci. 2017 Oct 5. doi: 10.1007/s10620-017-4775.
    PubMed     Abstract available


  357. REDMAN JS, Natarajan Y, Hou JK, Wang J, et al
    Accurate Identification of Fatty Liver Disease in Data Warehouse Utilizing Natural Language Processing.
    Dig Dis Sci. 2017;62:2713-2718.
    PubMed     Abstract available


  358. KHOURY T, Asombang AW, Berzin TM, Cohen J, et al
    The Clinical Implications of Fatty Pancreas: A Concise Review.
    Dig Dis Sci. 2017;62:2658-2667.
    PubMed     Abstract available


    September 2017
  359. XING J, Spradling PR, Moorman AC, Holmberg SD, et al
    A Point System to Forecast Hepatocellular Carcinoma Risk Before and After Treatment Among Persons with Chronic Hepatitis C.
    Dig Dis Sci. 2017 Sep 30. doi: 10.1007/s10620-017-4762.
    PubMed     Abstract available


  360. PARIKH ND, Fu S, Rao H, Yang M, et al
    Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USA.
    Dig Dis Sci. 2017 Sep 25. doi: 10.1007/s10620-017-4776.
    PubMed     Abstract available


  361. ROSEN E, Bakshi N, Watters A, Rosen HR, et al
    Hepatic Complications of Anorexia Nervosa.
    Dig Dis Sci. 2017 Sep 20. doi: 10.1007/s10620-017-4766.
    PubMed     Abstract available


  362. ZHANG S, Xiao J, Chai Y, Du YY, et al
    LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
    Dig Dis Sci. 2017 Sep 18. doi: 10.1007/s10620-017-4759.
    PubMed     Abstract available


  363. HOSSAIN N, Puchakayala B, Kanwar P, Verma S, et al
    Risk Factor Analysis Between Newly Screened and Established Hepatitis C in GI and Hepatology Clinics.
    Dig Dis Sci. 2017 Sep 14. doi: 10.1007/s10620-017-4754.
    PubMed     Abstract available


  364. IKEDA K, Kawamura Y, Kobayashi M, Kominami Y, et al
    Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Sep 7. doi: 10.1007/s10620-017-4739.
    PubMed     Abstract available


  365. OGISO H, Ito H, Kanbe A, Ando T, et al
    The Inhibition of Indoleamine 2,3-Dioxygenase Accelerates Early Liver Regeneration in Mice After Partial Hepatectomy.
    Dig Dis Sci. 2017;62:2386-2396.
    PubMed     Abstract available


  366. LUTZ P, Goeser F, Kaczmarek DJ, Schlabe S, et al
    Relative Ascites Polymorphonuclear Cell Count Indicates Bacterascites and Risk of Spontaneous Bacterial Peritonitis.
    Dig Dis Sci. 2017;62:2558-2568.
    PubMed     Abstract available


  367. DE LEDINGHEN V, Hiriart JB, Vergniol J, Merrouche W, et al
    Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan((R)): A Comparative Study with the M Probe and Liver Biopsy.
    Dig Dis Sci. 2017;62:2569-2577.
    PubMed     Abstract available


    August 2017
  368. CHEDID MF
    Nonalcoholic Steatohepatitis: The Second Leading Indication for Liver Transplantation in the USA.
    Dig Dis Sci. 2017 Aug 24. doi: 10.1007/s10620-017-4724.
    PubMed    


  369. CHENG L, Wang H, Han S
    MiR-3910 Promotes the Growth and Migration of Cancer Cells in the Progression of Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Aug 19. doi: 10.1007/s10620-017-4670.
    PubMed     Abstract available


  370. KIM JK, Kim HD, Jun MJ, Yun SC, et al
    Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Aug 16. doi: 10.1007/s10620-017-4708.
    PubMed     Abstract available


  371. XU H, Xiong J, Xu J, Li S, et al
    Mosapride Stabilizes Intestinal Microbiota to Reduce Bacterial Translocation and Endotoxemia in CCl4-Induced Cirrhotic Rats.
    Dig Dis Sci. 2017 Aug 16. doi: 10.1007/s10620-017-4704.
    PubMed     Abstract available


  372. GREMIDA A, Al-Taee A, Alcorn J, McCarthy D, et al
    Hepatic Dysfunction in Renal Cell Carcinoma: Not What You Think?
    Dig Dis Sci. 2017 Aug 7. doi: 10.1007/s10620-017-4706.
    PubMed    


  373. LEE HW, Kim BK, Kim SU, Park JY, et al
    Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2017;62:2150-2158.
    PubMed     Abstract available


  374. JIMENEZ JV, Carrillo-Perez DL, Rosado-Canto R, Garcia-Juarez I, et al
    Electrolyte and Acid-Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach.
    Dig Dis Sci. 2017;62:1855-1871.
    PubMed     Abstract available


    July 2017
  375. CHOLANKERIL G, Wong RJ, Hu M, Perumpail RB, et al
    Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
    Dig Dis Sci. 2017 Jul 25. doi: 10.1007/s10620-017-4684.
    PubMed     Abstract available


  376. EUN HS, Lee BS, Kwon IS, Yun GY, et al
    Advantages of Laparoscopic Radiofrequency Ablation Over Percutaneous Radiofrequency Ablation in Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Jul 25. doi: 10.1007/s10620-017-4688.
    PubMed     Abstract available


  377. SARTINI A, Gitto S, Villa E
    Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients?
    Dig Dis Sci. 2017 Jul 4. doi: 10.1007/s10620-017-4665.
    PubMed    


    June 2017
  378. YANG C, Gomez A, Haldipur A, Berquist W, et al
    Growing Concerns: A 3-Year-Old Girl with Multiple Hepatic Masses and Gastrointestinal Bleeding.
    Dig Dis Sci. 2017 Jun 23. doi: 10.1007/s10620-017-4644.
    PubMed    


  379. FITTIPALDI S, Vasuri F, Bonora S, Degiovanni A, et al
    miRNA Signature of Hepatocellular Carcinoma Vascularization: How the Controls Can Influence the Signature.
    Dig Dis Sci. 2017 Jun 21. doi: 10.1007/s10620-017-4654.
    PubMed     Abstract available


  380. WU S, Yang C, Xu N, Wang L, et al
    The Protective Effects of Helix B Surface Peptide on Experimental Acute Liver Injury Induced by Carbon Tetrachloride.
    Dig Dis Sci. 2017;62:1537-1549.
    PubMed     Abstract available


  381. SAFADI S, Mohamed AM, Altamimi BA, Strickland RG, et al
    Decompensated Liver Disease in a Patient with Neurocysticercosis.
    Dig Dis Sci. 2017;62:1443-1447.
    PubMed    


    May 2017
  382. PANTHAM G, Post A, Venkat D, Einstadter D, et al
    A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis.
    Dig Dis Sci. 2017 May 30. doi: 10.1007/s10620-017-4630.
    PubMed     Abstract available


  383. WALLACE MC, Huang Y, Preen DB, Garas G, et al
    HKLC Triages More Hepatocellular Carcinoma Patients to Curative Therapies Compared to BCLC and Is Associated with Better Survival.
    Dig Dis Sci. 2017 May 25. doi: 10.1007/s10620-017-4622.
    PubMed     Abstract available


  384. DE MATTEIS S, Granato AM, Napolitano R, Molinari C, et al
    Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 May 19. doi: 10.1007/s10620-017-4615.
    PubMed     Abstract available


  385. ROGAL SS, McCarthy R, Reid A, Rodriguez KL, et al
    Primary Care and Hepatology Provider-Perceived Barriers to and Facilitators of Hepatitis C Treatment Candidacy and Adherence.
    Dig Dis Sci. 2017 May 18. doi: 10.1007/s10620-017-4608.
    PubMed     Abstract available


  386. TAVAKOLI H, Robinson A, Liu B, Bhuket T, et al
    Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 May 4. doi: 10.1007/s10620-017-4595.
    PubMed     Abstract available


  387. DOYCHEVA I, Watt KD, Rifai G, Abou Mrad R, et al
    Increasing Burden of Chronic Liver Disease Among Adolescents and Young Adults in the USA: A Silent Epidemic.
    Dig Dis Sci. 2017;62:1373-1380.
    PubMed     Abstract available


  388. GAIDOS JKJ, Fuchs M
    Increased Prevalence of NAFLD in IBD Patients.
    Dig Dis Sci. 2017;62:1362.
    PubMed    


    April 2017
  389. HAMARNEH SR, Kim BM, Kaliannan K, Morrison SA, et al
    Intestinal Alkaline Phosphatase Attenuates Alcohol-Induced Hepatosteatosis in Mice.
    Dig Dis Sci. 2017 Apr 19. doi: 10.1007/s10620-017-4576.
    PubMed     Abstract available


  390. YOSHIDA T, Akiba J, Matsui T, Nakamura K, et al
    Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice.
    Dig Dis Sci. 2017 Apr 1. doi: 10.1007/s10620-017-4550.
    PubMed     Abstract available


  391. TESCHKE R, Eickhoff A
    Suspected Liver Injury and the Dilemma of Causality.
    Dig Dis Sci. 2017;62:1095-1098.
    PubMed     Abstract available


    March 2017
  392. CARR RM, Patel A, Bownik H, Oranu A, et al
    Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2017 Mar 6. doi: 10.1007/s10620-017-4495.
    PubMed     Abstract available


  393. KOHLI DR, Vachhani R, Shah TU, BouHaidar DS, et al
    Diagnostic Accuracy of Laboratory Tests and Diagnostic Imaging in Detecting Biliary Strictures After Liver Transplantation.
    Dig Dis Sci. 2017 Mar 6. doi: 10.1007/s10620-017-4515.
    PubMed     Abstract available


  394. O'LEARY JG, Wong F, Reddy KR, Garcia-Tsao G, et al
    Gender-Specific Differences in Baseline, Peak, and Delta Serum Creatinine: The NACSELD Experience.
    Dig Dis Sci. 2017;62:768-776.
    PubMed     Abstract available


  395. HEIDEMANN L, Law J, Fontana RJ
    A Text Searching Tool to Identify Patients with Idiosyncratic Drug-Induced Liver Injury.
    Dig Dis Sci. 2017;62:615-625.
    PubMed     Abstract available


    February 2017
  396. LIN MX, Ye JY, Tian WS, Xu M, et al
    Risk Factors for Bile Duct Injury After Percutaneous Thermal Ablation of Malignant Liver Tumors: A Retrospective Case-Control Study.
    Dig Dis Sci. 2017 Feb 15. doi: 10.1007/s10620-016-4312.
    PubMed     Abstract available


  397. BALAKRISHNAN M, El-Serag HB, Kanwal F, Thrift AP, et al
    Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey.
    Dig Dis Sci. 2017;62:526-533.
    PubMed     Abstract available


  398. KUO SZ, Haftek M, Lai JC
    Factors Associated with Medication Non-adherence in Patients with End-Stage Liver Disease.
    Dig Dis Sci. 2017;62:543-549.
    PubMed     Abstract available


    January 2017
  399. ZHAO D, Luo Y, Xia Y, Zhang JJ, et al
    MicroRNA-19b Expression in Human Biliary Atresia Specimens and Its Role in BA-Related Fibrosis.
    Dig Dis Sci. 2017 Jan 12. doi: 10.1007/s10620-016-4411.
    PubMed     Abstract available


  400. LEIBOVICI-WEISSMAN Y, Mor E, Leshno M, Shlomai A, et al
    Patients' Age Rather Than Model of End-Stage Liver Disease Score Predicts Survival After Liver Transplantation.
    Dig Dis Sci. 2017 Jan 4. doi: 10.1007/s10620-016-4423.
    PubMed     Abstract available


  401. SRIDHAR A, Cwiak CA, Kaunitz AM, Allen RH, et al
    Contraceptive Considerations for Women with Gastrointestinal Disorders.
    Dig Dis Sci. 2017;62:54-63.
    PubMed     Abstract available


    November 2016
  402. DONOVAN RJ, Choi C, Ali A, Heuman DM, et al
    Perioperative Cardiovascular Evaluation for Orthotopic Liver Transplantation.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


    October 2016
  403. HA TH, Kim BG, Jeong D, Oh S, et al
    Alcoholic Liver Disease Is Associated with an Increased Risk of Gastric Cancer.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


    August 2016
  404. SOTIROPOULOS GC, Vernadakis S, Paul A, Hoyer DP, et al
    Single-Center Experience on Liver Transplantation for Model for End-Stage Liver Disease Score 40 Patients.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


    July 2016
  405. HEGADE VS, Khanna A, Walker LJ, Wong LL, et al
    Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk Score.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


    March 2016
  406. JARUVONGVANICH V, Sanguankeo A, Upala S
    Significant Association Between Gallstone Disease and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: